WO2000055579A2 - A system and method for detection and characterization of stenosis, blood vessels flow and vessel walls properties using vessel geometrical measurements - Google Patents

A system and method for detection and characterization of stenosis, blood vessels flow and vessel walls properties using vessel geometrical measurements Download PDF

Info

Publication number
WO2000055579A2
WO2000055579A2 PCT/IL2000/000172 IL0000172W WO0055579A2 WO 2000055579 A2 WO2000055579 A2 WO 2000055579A2 IL 0000172 W IL0000172 W IL 0000172W WO 0055579 A2 WO0055579 A2 WO 0055579A2
Authority
WO
WIPO (PCT)
Prior art keywords
processor unit
pressure
operative
wave velocity
signal
Prior art date
Application number
PCT/IL2000/000172
Other languages
French (fr)
Other versions
WO2000055579A3 (en
Inventor
Elhanan Dgany
Simon Henri Noskowicz
Evgeny Shalman
Chen Barak
Michael Simkhis
Original Assignee
Florence Medical Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florence Medical Ltd. filed Critical Florence Medical Ltd.
Priority to AU2000233210A priority Critical patent/AU2000233210A1/en
Publication of WO2000055579A2 publication Critical patent/WO2000055579A2/en
Publication of WO2000055579A3 publication Critical patent/WO2000055579A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026Measuring blood flow
    • A61B5/0285Measuring or recording phase velocity of blood waves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • A61B5/0215Measuring pressure in heart or blood vessels by means inserted into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/04Measuring blood pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/48Diagnostic techniques
    • A61B8/485Diagnostic techniques involving measuring strain or elastic properties

Definitions

  • the present invention relates to the field of medical diagnostic and therapeutic devices for characterization of blood vessel lesions and properties using invasive and noninvasive measurements.
  • Vascular diseases are often manifested by reduced blood flow due to atherosclerotic occlusion of vessels.
  • occlusion of the coronary arteries supplying blood to the heart muscle is a major cause of heart disease.
  • Invasive procedures for relieving arterial blockage such as bypass surgery and balloon dilatation with a catheter are currently performed relying on estimates of the occlusion characteristics and the blood flow through the occluded artery. These estimates are based on measurements of occlusion size and / or blood flow.
  • current methods of occlusion size and blood flow measurement have low resolution, are inaccurate, are time consuming, require expertise in the interpretation of the results and are expensive.
  • decisions on whether or not to use any of the blockage relieving methods and which of the methods should be used are often based on partial information. The evaluation of therapeutic success is also problematic, where both occlusion opening and stent position have to be evaluated.
  • TCT transcatheter cardiovascular therapeutics
  • CABG coronary artery bypass grafting
  • Atherosclerotic lesions may have different characteristics. Some lesions exhibit a variable degree of calcification while others have a fatty or thrombotic nature. Lesion characteristics together with vessel condition proximal and distal to the lesion are the major factors for determining the therapeutic procedure needed.
  • TCT starts with an interventional diagnosis procedure (angiography), followed by the treatment of the patient with medication therapy.
  • CABG continuation of the TCT procedure with adequate interventional treatment.
  • PTCA percutaneous transluminal angioplasty
  • DC A directional coronary atherectomy
  • RCA rotational coronary atherectomy
  • TEC transluminal extraction catheter
  • ELCA excimer laser angioplasty
  • stents are placed within the lesion so as to prevent re-closure of the vessel (also known as recoil). If the stent is malpositioned, it interrupts the flow and may initiate restenosis.
  • Lesion characteristics are used to determine the medically and economically optimal treatment method or combination of methods of choice.
  • Angiography has been the main diagnostic tool in the catheter laboratory.
  • the physician uses the angiographical images in order to identify and locate the lesions, evaluate the occlusion level (percentage of normal diameter) and qualitatively estimate the perfusion according to "thrombolysis in myocardial infarction" (TIMI) grades, determined according to the contrast material appearance.
  • TIMI grades 0,1,2,3 represent no perfusion, minimal perfusion, partial perfusion and complete perfusion, respectively.
  • QCA quantitative coronary angiography
  • IVUS intravascular ultrasound
  • IDVS intravascular Doppler velocity sensor
  • IPS intravascular pressure sensor
  • IVUS provides accurate geometrical data regarding cross section area and accurate information regarding the vessel wall structure and composition.
  • IDVS provides velocity measurements, enabling discriminating various degrees of occlusion according to coronary flow reserve (CFR) criteria. IDVS suffers from inaccuracy problems resulting from positioning errors within the vessel.
  • IPS provides pressure measurements enabling discriminating various degrees of occlusion according to the FFR (fractional flow reserve) criteria. Angiography and the sophisticated techniques discussed above may be employed prior to and after the therapeutic procedure (the last for the evaluation of the results and decision about correcting actions).
  • the device is used for Noninvasive Examination of Input Vascular Impedance, elasticity of Arterial Walls and volumetric blood flow.
  • Impedance is defined here as the ratio between blood pressure and blood flow in the linear approximation of blood flow.
  • the apparatus is claimed to be a computerized Ultrasonic system consisting of a double ultrasonic probe locates at the same position along the artery. Both probes operate simultaneously, the first probe in the Echo-mode measures instantaneous vessel diameter and the second probe is in a CW-Doppler mode and measures blood flow (i.e., blood velocity). Being a single position probe, elasticity of the artery cannot be calculated by vessel diameter alone.
  • the invention discloses a method and devices for determining volume flow, blood velocity profile, artery wall properties of a tubular conduit system and stenosis identification and localization by introducing an artificial pressure or flow excitation signal (a single signal or multiple signals) into the blood vessel (or in any other tubular flowing fluid conduits), and or using natural heart beat signals measurement and analysis of the vessel wall displacements or vessel diameter changes.
  • an artificial pressure or flow excitation signal a single signal or multiple signals
  • This invention provides an apparatus, and system for determining volume flow, blood velocity profile, and/or artery wall properties of a tubular conduit system and stenosis identification and localization, said apparatus comprising: a means for generating an artificial pressure signal or an artificial pressure wave velocity; a means for measuring artery diameter or displacement resulting from said artificial pressure signal or an artificial pressure wave velocity or using natural heart beat signals; a processor unit operatively connected to said measuring means; a program for controlling the processor unit, wherein said processor unit is operative with said program to receive said signal which is represented of the measure of said artery diameter or displacement resulting from said artificial pressure signal or an artificial pressure wave velocity or using natural heart beat signals and determine volume flow, blood velocity profile, and/or artery wall properties from analysis of the vessel wall displacements or vessel diameter changes.
  • the processor unit is operative to select a method from a plurality of methods to generate artificial pressure signal or an artificial pressure wave velocity or using natural heart beat signals.
  • the tubular conduit system is a blood vessel system and said processor unit is operative to detect changes in arterial characteristics.
  • the processor unit is operative to determine volume flow.
  • the processor unit is operative to detect stenosis.
  • the processor unit is operative to determine blood velocity profile.
  • the measuring means is by ultrasound or magnetic motion sensor. In another embodiment, the measuring means is by ultrasound. In another embodiment, the measuring means is by magnetic motion sensor. In another embodiment, the means for generating a pressure signal is in by a non-invasive means. In another embodiment, the means for generating a pressure signal is by an exciter. In another embodiment, the non-invasive means for generating a comprises a mechanical and/or electrical means. In another embodiment, the mechanical non-invasive means for generating a comprises applying pressure to the carotid.
  • the signal is a plurality of discrete signals said processor unit is operative to sample said discrete signals and receive pressure wave velocity data. In another embodiment, the processor unit is operative to perform a single pressure function using said discrete signals and said pressure wave velocity data.
  • This invention provides a method for determining volume flow, blood velocity profile, and/or artery wall properties of a tubular conduit system and stenosis localization, comprising: generating an artificial pressure signal or an artificial pressure wave velocity or using natural heart beat signals; and measuring artery diameter or displacement resulting from said artificial pressure signal or an artificial pressure wave velocity; thereby determining volume flow, blood velocity profile, and/or artery wall properties of a tubular conduit system.
  • the processor unit is operative to select a method from a plurality of methods to generate artificial pressure signal or an artificial pressure wave velocity.
  • the tubular conduit system is a blood vessel system and said processor unit is operative to detect changes in arterial characteristics.
  • the processor unit is operative to determine volume flow.
  • the processor unit is operative to detect stenosis.
  • the processor unit is operative to determine blood velocity profile.
  • the measuring means is by ultrasound or magnetic motion sensor. In another embodiment, the measuring means is by ultrasound. In another embodiment, the measuring means is by magnetic motion sensor. In another embodiment, the means for generating a pressure signal is in by a non-invasive means. In another embodiment, the means for generating a pressure signal is by an exciter. In another embodiment, the non-invasive means for generating a comprises a mechanical and/or electrical means. In another embodiment, the mechanical non-invasive means for generating a comprises applying pressure to the carotid.
  • the signal is a plurality of discrete signals said processor unit is operative to sample said discrete signals and receive pressure wave velocity data. In another embodiment, the processor unit is operative to perform a single pressure function using said discrete signals and said pressure wave velocity data.
  • This invention provides a method of determining the geometrical shape of the stenosis. Such determination as provided for herein is determined by comparing the pressure signal proximal to the stenosis to the pressure signal distal to the stenosis so as determine the geometrical shape of the stenosis. In another embodiment the reflection method as disclosed herein is determined and then based on the reflection the geometrical shape of the stenosis is determined.
  • This invention provides a method and devices may also serve for evaluating the success of medical treatment. For example tracking sufficient opening for determining volume flow, blood velocity profile, and/or artery wall properties of a tubular conduit system occlusion or malpositioning of a stent. It may also serve for the characterization of vascular bed, downstream the vessel.
  • the present invention provides a method for further analysis of the response to the excitation signal yielding a quantitative determination of elastic properties of blood vessel walls for characterizing, wter alia, the distensibility and the compliance of lesioned and non-lesioned parts of blood vessels.
  • the derived elastic properties may be further used to determine the degree of calcification of lesioned and non-lesioned parts of blood vessels.
  • Figure 1 illustrates an ultrasound measuring system for measuring vessel wall displacements or vessel diameter changes caused by heartbeats pressure signals.
  • Figure 2 illustrates an ultrasound measuring system for measuring vessel wall displacements or vessel diameter changes caused by artificial pressure signals
  • Figure 3 illustrates an exciter use for generating artificial pressure signal inside a blood vessel.
  • Figure 4 illustrates an in vitro test apparatus used to verify the analytical results
  • Figure 5 is a zoom on part of the in vitro test apparatus illustrated in Fig. 4.
  • Figure 6 is a schematic description of the in vitro test apparatus.
  • Figure 7 illustrates the Magnetic Motion Sensor incorporated within the in vitro test apparatus and used to measure tube wall displacements caused by pressure signal.
  • Figure 8 illustrate the MMS together with the in vitro test apparatus.
  • Figure 9 illustrates the test set up used in the experiment for flow determination.
  • Figure 10 illustrates an in vitro test performed in order to determined the distensibility of the latex tube.
  • Figure 1 1 illustrates the results of the in vitro test for determining the distensibility of the latex tube.
  • Figure 12 illustrates test results of pressure measurements versus MMS output voltage.
  • Figure 13 illustrates the pulses measured by the MMS in experiment for determining pressure wave velocity.
  • Figure 14 is a graph illustrating comparison of the volume flow rate as a function of time as computed using model 2 and the flow as obtain from flow meter measurements.
  • Figure 15 is a graph illustrating the tube wall shear stress as a function of time as calculated from data obtained from two experiments with different flow rate.
  • Figure 16 illustrates flow axial velocity profile as calculated from the data obtained from an in vitro test.
  • Figure 17 is a plot of computed axial centerline velocity using model 1.
  • Figure 18 is a graph illustrating comparison of the volume flow rate as a function of time as computed using model 1 and the flow as obtain from flow meter measurements.
  • Figure 19 illustrates comparison between the flow calculated from model 1 and 2for two different flow rates.
  • Figure 20 illustrates a test setup for identifying and localizing stenosis.
  • Figure 21 is a plot of the proximal and distal signal measured by the MMS in an in vitro test for identifying and localizing of a stenosis.
  • Figure 22 is a zoom on the peaks of the pulses illustrated in Fig. 21.
  • the present invention gives a method for deducing the volume flow rate, velocity profile, properties of artery walls (compliance and distensibility) and stenosis detection and localization.
  • the method uses measurement of blood vessel cross section area (or diameter if the artery is quasi-circular) as a function of time.
  • pressure and pressure wave velocity are derived from vessel area (or diameter) measurements enabling the determination of flow, wall properties and stenosis location.
  • the method is designed to serve as a diagnostic tool for the physician when emphasis is put on optimizing measurement duration, computer resources and data processing time.
  • knowing the area A(x,t), or diameter, D(x,t) is equivalent to knowing pressure.
  • the pressure gradient when pressure is transversally constant
  • the other is the pulsatile motion of the tube, which acts on the fluid through the no-slip condition enforcing zero fluid velocity (axial, radial and circumferential) at the wall.
  • Flow, stenosis location and vessel wall properties are computed from geometrical measurements of blood vessel (wall displacement or artery diameter).
  • Vessel diameter is measured using an ultrasound device or any other noninvasive device as for example described below. If an ultrasound apparatus is used, it must have a probe with at least two ultrasound lines at two different neighboring locations with known distance between them. The probe operates the two lines simultaneously in Echo-mode and measures vessel diameter. Pressure is derived from diameter measurements. The data is processed to yield two diameters which are functions of time.
  • FIG. 1 illustrating the measuring system.
  • An ultrasound-measuring device (1) is attached to a processor unit (3) and measures changes in blood vessel diameter (2) as a function of time. The changes in diameter are due to pressure pulses caused by heartbeats. Measurements are performed at two neighboring points. A stenosis (4) might be present, distally, in which case it will be detected. From these geometrical measured data, flow, stenosis location (if present) and artery wall properties are computed.
  • the displacements of artery walls may be determined using more than two measuring points along the artery. In such a case P(x,t) is derived from the multi number of measurements.
  • the displacements of artery walls may be determined using ultrasound measurement of a single artery section. In such case, a second measurement of another section, located at a known distant from first section is performed later. Then time synchronization of the measured results has to be performed.
  • the displacements of artery walls may be determined using Magnetic Motion Sensor (MMS) which measures the vessel wall displacements.
  • MMS Magnetic Motion Sensor
  • Such a device capable of measuring wall displacements of latex tube is incorporated within an in vitro test system.
  • the laboratory MMS device is illustrated in Figs 7 and 8.
  • a device, based on the same principles, may be adjusted for clinical purposes and used for measuring vessel wall displacements. This is possible in cases of arteries located close enough to the body external skin, such as the carotid.
  • an exciter (a short duration pulses generator) may be used.
  • the exciter (5) generates an artificial pressure pulse that propagates along the vessel.
  • the pressure pulse is introduced into the vessel by a catheter (6).
  • the changes in vessel diameter (2) caused by the excited pressure signal going forward and the reflected signal coming backward from a stenosis (4) are measured by an ultrasound device (1).
  • the changes in diameter are better detected and measured than those caused by heartbeats. This improves the accuracy of measurements and results.
  • the exciter is a device for the excitation of the pressure waves inside the tube (catheter). It consists of a hammer (7) and conical chamber (8). Low voltage is applied to the solenoid (not shown) that pushes the weight (hammer). This weight strikes the membrane (9) of the conical chamber thus initiating a short pressure pulse.
  • the opening of the cone is connected to a catheter (6). In the initial state the chamber and the catheter are filled with the fluid. The movement of the membrane is allowed only in one direction, so only positive pressure pulse is produced. The membrane returns to its initial position by the effect of a spring. Displacement of the membrane and pressure wave generation could be achieved as well by using an actuator based on piezoelement or other pressure generating device.
  • the methods provided herein are based on introducing an artificial pressure signal into the blood vessel.
  • the pressure signal originates from a pressure signal generator (PSG).
  • PSG pressure signal generator
  • a PSG of the type suitable for this purpose is a "blood pressure systems calibrator” model 601 A, commercially available from Bio-Tek Instruments Inc., Highland Park, Box 998, Winooski, VT-05404-0998, U.S.A.
  • Catheterization laboratory injection systems are known to those skilled in the art.
  • a system of the type suitable for this purpose is a "Mark V Plus Injection System" from Medrad, inc. 271 Kappa Drive, Pittsburgh,PA 15238-2870 U.S.A.
  • a pressure signal generated within the catheter or in its distal tip e.g. piezoelectrically or by another form of energy burst introduction e.g. AcolysisSystem, ultrasound thrombolysis selective lysis of fibrin, by Angiosonics Inc., NC, U.S.A.
  • a pressure signal generated within the catheter or in its distal tip is by the movement of an hydrodynamic surface, activated either manually or by a special mechanism (e.g catheter used for removing malpositioned or embolized stents, for example Amplatz Goose Neck Snare GN 500 and Microsnare SK200 from Microvena corporation, Minnesota USA and catheters which prevent plaque debris from moving downstream);
  • a pressure signal caused by an external controlled pressure applied on an organ transmitted into a pressure signal within the vessel;
  • a pressure signal caused by a non-invasive energy transmission into the vessel e.g. ultrasound in which the artificial pressure/flow signal may be either controlled or measured (within the catheter or the vessel).
  • the methods provided herein are based on using natural heart beat signals measurement and analysis of the vessel wall displacements or vessel diameter changes.
  • the signal generator is a pressure signal generator; said signal sensor is a pressure signal sensor; and said processor unit is operative to receive a heart beat signal; and synchronize receipt of said probe signal with said heart beat signal.
  • the signal sensor includes at least two sensing transducers disposed in spaced apart relation. The signal sensor is movable between at least two positions relative to said tubular conduit system and said processor unit is operative to calculate a pressure wave velocity from signals received from said two positions.
  • the signal sensor includes a signal conditioner. The signal may be derived from either one of the internally generated waveforms or excited electronically from a separate signal generator either a stand alone unit.
  • a stand alone unit is of the type suitable is a multifunction synthesizer model HP8904A from HP Test and measurement Organization, a Hewlett Packard company USA) or integrated within a system computer, otherwise used for data acquisition and analysis.
  • HP8904A from HP Test and measurement Organization, a Hewlett Packard company USA
  • an electric impulse generator is shown in Figure 29.
  • the pressure signal may originate from an impact mechanism system.
  • impact mechanisms are known to those skilled in the art.
  • the impact mechanisms may be of the spring loaded or electronically activated mechanical impact system types, applying pressure on either the catheter or on a container attached to it.
  • a signal generation apparatus (in vitro and in vivo) of the impact mechanism type makes use of a pistol hammer mechanism, where the pistol hammer hits directly on the catheter, lying on a rigid surface.
  • the pistol used was a P230 semiautomatic pistol from Sig Sauer, Switzwerland.
  • the same pistol hammer hit the head of a standard 5 ml syringe, where the syringe was connected to the catheter through a standard manifold.
  • the artificial pressure flow signal may also be synchronized with heart beats, either by gating to ECG or to system measurements (pressure or flow) in which the ECG device measures heart heat signals upon reaching a desired time in the heart beat triggering the artificial pressure flow signal.
  • the pressure signal advances through a catheter lumen into the blood vessel.
  • the catheter may be a guiding catheter.
  • a guiding catheter of the type suitable for this purpose is a 8F Archer coronary guiding catheter from Medtronic Interventional Vascular, Minneapolis, U.S.A.
  • a diagnostic catheter of the type suitable for this purpose is a Siteseer diagnostic catheter, from Bard Cardiology. U.S.A.
  • a balloon catheter of the type suitable for this purpose is a Supreme fasr exchange PTCA catheter, by Biotronik GMBH & Co, U.S.A. It should be noted that almost any type of hollow catheter may be used.
  • the presence of occlusion or aneurysm downstream creates reflection of pressure and flow waves. By extracting data of the reflected pressure waves, originated in the occluded site, the location and degree of occlusion can be determined using signal processing methods.
  • the performance of pressure wave velocity and reflection site parameters (position and reflection coefficient) estimation is based on two-point pressure measurement carried out inside of an artery.
  • the pressure is measured either simultaneously by two pressure sensors or in different time by single sensor with some additional synchronization mechanism. In the case of the simultaneously pressure measurement two pressure sensors are placed throw known distance d. In the single sensor case the pressure is firstly measured in point a (upstream) and after that - in point b (downstream).
  • Compliance and distensibility are related to Pressure Wave Velocity as follows:
  • the pressure velocity c is related to the measured Pressure wave velocity (PWV) through:
  • Ao is the area corresponding to an internal reference pressure Po.
  • Human arteries are stiffer at higher pressure.
  • Several empirical models have been proposed and may be used for more accurate results.
  • ho and Do are the wall thickness and arterial diameter at reference pressure Po, respectively and E is the effective elastic modulus.
  • E is the effective elastic modulus.
  • a popular model is the one of Langewouters et al., (1984) using an arctangent function and three optimal fit parameters:
  • Model 1 Transversally averaged Fluid Dynamics Equations:
  • This model is a quasi-linear model in which the fluid dynamical equations are integrated over the cross section. It is especially useful for arteries in which the cross-section is manifestly non-circular. In effect it transforms the full three dimensional flow equation to one-dimensional ones in the couple Q and P where Q(x,t) is the volume flow rate or alternatively A and Q since A and P are related through compliance.
  • Q(x,t) is the volume flow rate or alternatively A and Q since A and P are related through compliance.
  • the price of such a drastic simplification is the introduction of empirical constants. Fortunately, these constants have a small effect so that they need not be known with great accuracy.
  • the basic equations are the continuity and momentum equations (Navier-Stokes). It is convenient to use cylindrical coordinate where x is the axial coordinate along the tube, r is the radial coordinate and ⁇ is the circumferential angle.
  • the parameter ⁇ varies between 1 for a blunt velocity profile and 4/3 for a parabolic velocity profile. In arteries it is observed that ⁇ is very close to one. In addition, the quadratic term is very small, except possibly at severe constrictions (stenoses).
  • the integral on the r.h.s. represents the force exerted by the wall on the fluid.
  • the wall shear stress (WSS) conventionally denoted by ⁇ having dimensions of a pressure is defined as:
  • Eqs (17) and (22) are the one-dimensional equations for A and Q in the long-wave-length approximation.
  • quadratic term in Q and the stress one recovers the well-known linear model. It remains to find an appropriate model for the WSS as well as ?.
  • the pressure drop in a pulsatile flow is mainly due to both viscous effects and to a pressure force for flow acceleration.
  • the PoiseuiUe WSS for a steady flow is 8 ⁇ proportional to - Q whereas the inertial force is proportional to the time derivative pA of Q.
  • the coefficients c u and c v are slowly varying coefficients depending on the Womersley number: ⁇ p a R (24) ⁇
  • the first term in the stress expression is the usual PoiseuiUe stress and the second one is an unsteady contribution.
  • aorta c » 1.1 and c u » 1.6.
  • a computational and clinical study should yield an optimal set of coefficients.
  • Compliance and distensibility are explicit functions of x.
  • the initial value of A as well as Q must be specified (i.e. A(x,0) and Q(x,0) for all x in the segment [0,L] ).
  • the difficulty resides in the absence of datum concerning the initial flow.
  • the initial conditions rapidly die off.
  • the system of equations is run with arbitrary initial conditions (e.g., zero flow) with repeating the datum for a few periods (up to ten periods, typically) until the system settles in the periodic regime.
  • Model 2 relates to a generalized case where the artery is with or without tapering.
  • the case of no tapering is a simplified case of model 2.
  • V x (r,x,t) f 0 (r,t)+xf x (r,t) (38a) dP(z, t)
  • the boundary conditions are along the centerline
  • the minimal areas at the N x positions are recorded by selecting the minimal area in time at each of those positions.
  • Pressure signals are computed according to the compliance model. For example: from the formula in the constant distensibility mode one obtains the N x signals:
  • N x values of (x, , t, ) are constructed through the N ⁇ positions points on the measured segment. This is necessary for solving the numerical equations by finite differences or finite elements. For example, in the case of two measuring points x and Xi+L Pix ⁇ -Pi ⁇ +JL ⁇ t j )
  • the pressure gradient is dP ( - + x 3 )P(x, , t ) (x, + x 3 )R(x 2 , t ) (x, + x 2 )R(x 3 , t )
  • the non invasive sensors measure diameters and upon using the Pressure- Area (or diameter) relation the pressure signal are obtained.
  • the pressure wave can be linearly decomposed into a forward moving and backward moving wave, P f (x,t) and P b (x,t) , respectively.
  • the pressure wave is a sum of a forward and backward moving wave:
  • the backward wave originates from reflection of the forward wave at the stenosis and in the linear approximation the forward wave of angular frequency ⁇ yields a reflected wave of the same frequency multiplied by a (complex) reflection coefficient R( ⁇ ) so that :
  • proximal and distal sensors have coordinate "0" and "Z", respectively.
  • the backward wave at a given sensor is equal to R times the path from the sensor to the stenosis and back; the path equals 2L for the proximal sensor and (2L-Z) for the distal sensor.
  • F( ⁇ ) and G( ⁇ ) denote the Fourier transforms of P(0,t) and P(Z,t), respectively. They are equal to the expressions multiplying exp(-j ⁇ t) under the integral sign. Upon dividing F( ⁇ ) by G( ⁇ ) it follows that:
  • the ratio of the Fourier transforms of the proximal and distal pressure pulses is a known function of ⁇ , R, L and Z and CC( ⁇ ).
  • Z the distance between probes is known.
  • the PWV can be computed using the method described here in above. There remain, three parameters R, L (the distance to the stenosis) and the attenuation coefficient, ⁇ . To be computed. In practice, a least-square fit procedure is the easiest method, as shown next (the left and right hand side of Eq.(62) are denoted, rat( ⁇ ) and t( ⁇ ), respectively). Then R, L and ⁇ are given by:
  • the integral is minimum at the physical values of R, L and ⁇ (the integral is taken over a frequency interval such that the proximal and distal power spectra are, say, at least 20 times larger than the power spectrum of the noise).
  • the reflection coefficient may be considered as a real number independent of frequency [Stergiopulos et all 996).
  • the main clinical application of the method is in detecting downstream stenosis which would otherwise be hidden from the other modalities.
  • the internal carotid is situated behind the jaw and thus opaque to B-mode ultrasound.
  • the wall of an artery closest to the skin is called the anterior wall, while the side farthest from the skin is the posterior wall. It has been observed that the anterior wall of a carotid undergoes a greater displacement than the posterior wall during a cardiac cycle (Reneman, Hoeks and Westerhof 1996). The same phenomenon might be observed in other peripheral arteries as well.
  • the PWV can be measured by measuring the time between arrival of the peaks of ⁇ ant(t,xj) and ⁇ ant(t,x 2 ) measured at times ti and t 2 , respectively.
  • the PWV, c is then given by:
  • FIG. 4, 5and 6 4 illustrating an in-vitro experimental apparatus constructed and operative for determining flow characteristics in simulated non lesioned and lesioned blood vessels,.
  • the fluidics system 51 of Fig. 4 is a recirculating system for providing pulsatile flow.
  • the system 51 includes a pulsatile pump 42 model 1421 A pulsatile blood pump, commercially available from Harvard Apparatus, Inc., Ma, U.S.A., however other suitable pulsatile pumps can be used.
  • the pump 42 allows control over rate, stroke volume and systole/diastole ratio.
  • the pump 42 re-circulates glycerin solution from a reservoir 15 to a reservoir 14.
  • the system 51 further includes a flexible tube 43 immersed in a water bath 44, to compensate for gravitational effects.
  • the flexible tube 43 is made from Latex and has a length of 120 cm.
  • the flexible tube 43 simulates an artery.
  • the flexible tube 43 is connected to the pulsatile pump 42 and to other system components by Teflon tubes. All the tubes in system 51 have 4 mm internal diameter.
  • a bypass tube 45 allows flow control in the system and simulates flow partition between blood vessels.
  • a Windkessel compliance chamber 46 is located proximal to the flexible tube 43 to control the pressure signal characteristics.
  • a Windkessel compliance chamber 47 and a flow control valve 48 are located distal to flexible tube 43 to simulate the impedance of the vascular bed.
  • the system also includes a flowmeter 1 1 connected distal to the flexible tube 43 and a flowmeter 12 connected to the bypass tube 45.
  • the flown meters 11 and 12 are suitably connected to A/D converter (not shown).
  • the flow meters 1 1 and 12 are model 111 turbine flow meters, commercially available from McMillan Company, TX, U.S.A.. In certain cases, an ultrasonic flow meter model T206, commercially available from Transonic Systems Inc., NY, U.S.A is used.
  • An exciter (5) is connected to the flexible tube (43) through a catheter (6) enable introducing pressure pulses inside the tube.
  • Fig. 5 is a schematic cross sectional view illustrating a part of the fluidics system 51 in detail.
  • An artificial stenosis made of a tube section 55, inserted within the flexible tube 43 is described.
  • the tube section 55 is made from a piece of Teflon tubing.
  • the internal diameter of the artificial stenosis 55 may be varied by using artificial stenosis sections fabricated separately and having various internal diameter.
  • the system 41 includes the system 51.
  • the system 41 also includes a signal conditioner 23 model TCB-500 control unit commercially available from Millar Instruments.
  • Data acquisition was performed using a PC - Pentium 586 (20 with an E series Instruments multifunction I/O board model PC-MIO-16E-4, commercially available from National Inc., TX, U.S.A.
  • the I/O board was controlled by a Labview graphical programming software, commercially available from National Instruments Inc., TX, U.S.A. 10 sec interval of pressure and flow data were sampled at 5000Hz, displayed during the experiments on the monitor and stored on hard disk. Analysis was performed offline using Matlab version 5 software, commercially available from The Math Works, Inc., MA, U.S.A.
  • Figs. 7 and 8 illustrating the magnetic motion sensor (MMS) device attached to the in vitro test system 51.
  • MMS magnetic motion sensor
  • the sensor array measures small changes in diameter along a latex tube while the tube inner diameter is under water pressure variation caused by a pump simulating a human heart. Tests show that the sensors are able to sense movements as small as a few microns in real time and that these movements correspond well to pressure measurements obtained simultaneously using a Radi pressure sensor inside the tubing. In order to minimize the effects of the sensor array on the latex tube Hall Effect sensors were arranged to measure movements of small magnets cemented to the surface of the latex tubing.
  • a total of six Hall Effect sensors are spaced at 2 CM intervals along the latex tubing and several MM above the tubing.
  • Small rare earth magnets are placed above and below the sensors with there like magnetic poles facing each other. This arrangement creates a magnetic field that is almost linear near the center point between the magnets.
  • the top magnet is fixed relative to the Hall effect sensor, while the lower magnet is free to move with the changing diameter of the tubing.
  • the opposite side of the tubing diameter is fixed to 2 MM diameter posts opposite each sensing position.
  • Each Hall Effect sensor generates an output voltage proportional to the change in magnetic field strength that is in turn proportional to the change in tubing diameter.
  • the sensor voltage is amplified by a low noise instrumentation amplifier followed by a differential output line driver which is drives a set of cables to the nearby data acquisition system.
  • the experiment was performed using the in vitro test apparatus illustrated in Figs. 4,5,6 using a flexible tube under the action of an external pulsating pump simulating heart beat.
  • the test configuration is illustrated in Fig. 9.
  • the pump is a pulsating HarvardTM pump producing pressure pulses simulating heartbeats.
  • the flexible tube is made of latex simulates blood vessel wall characteristics of 70 years old man.
  • the latex tube is filled by fluid consists of a 60 % water and 40 % glycerine mixture with a density of 1103 Kg/m and a measured viscosity close to the one measured in blood.
  • the data was acquired at a sampling rate equal to 5000 Hz and digitized using an A/D board.
  • the data acquisition was monitored with a LABVIEWTM program and then processed through a MatlabTM program (FID), (the sampling rate is much higher than needed for computations)
  • the MMS system output is voltage signal that follows the tube diameter changes caused by pressure variation in the vessel produced by the pump.
  • the voltage signal is translated into pressure units by means of sensor calibration.
  • For the pu ⁇ ose of calibration we use a single pressure sensor MillarTM in a static configuration. The sensor characteristic obtained was practically linear. Distensibility of the latex tube:
  • a pressure sensor 21 (Millar) is positioned in the experimental setup without pump. The pressure sensor is calibrated to zero pressure at atmospheric pressure. Both ends of the tube are closed whereas at one end a syringe is attached to the tube. The length of the tube is 1.31 m and the diameter of the tube filled with fluid at atmospheric pressure is 3.6 mm. The volume of the tube, Vo, (neglecting the Y-connectors) is 13.34 ml. The Syringe capacity is 2.4 ml. Small quantities of fluids are injected into the tube and the pressure read by the Millar sensor is plotted as a function of the logarithm of the volume in the tube, V 0 + ⁇ V. If the latex tube exhibits constant distensibility the following holds
  • Po' The value of Po' is the pressure at zero flow.
  • MMS Voltage as a function of time.
  • Several methods may be used. Basically the method computes the shift in time between arrivals of the pulses at the magnetic sensors. Due to imperfections in the systems such as tube instabilities, pump variations and other factors, there is a spread in the PWV values. A train of 44 pulses was selected and outliers eliminated (less than 8 m s and more than 20 m/s).
  • Fig. 16 illustrating a plot of the axial velocity profile for a single period with volume flow rate 120 ml/min. It is convenient to measure time by an angular variable, a whole period being 360 degrees. Velocity profiles as function of time for volume flow rate 120 ml/min
  • the maximum (or peak) velocity is seen to be situated along the centerline of the tube.
  • Doppler velocity was measured using a 0.0014 inch Doppler guide wire (FlowireTM, Cardiometrics, Inc., Mountain View CA).
  • a proprietary real-time fast Fourier analyzer (FlowmapTM Cardiometrics, Inc.) with automated tracking of the maximal velocity of the Doppler spectrum was employed to measure peak Doppler velocity.
  • the Doppler shift reflected by red cells is recorded (we use corn-flour starch, instead).
  • Fig. 17 illustrating a plot of the calculated centerline axial velocity using Model 1 (continuous curve) and the peak velocity as measured by the Flow ire.
  • the volume flow rate is 120 ml/min. Results using Model 1 :
  • Model 1 The computed volume flow rate using model 1 is plotted in Fig. 18 together with the output of the Flow-Meter.
  • the results are quite insensitive to small changes in these parameters.
  • Model 1 is more limited than Model 2, since its only output is volume flow rate. In the present situation were the tube is circular and there is no swirl, it is not advantageous to use Model 1.
  • Model 1 and Model 2 Reference is now made to Fig. 19 The volume flow rates given by Model 1 and Model 2 are compared and are almost identical.
  • Fig. 21 is a plot of the proximal and distal signal measured by the MMS.
  • the stenosis has a diameter of 1 mm and a length of 1 cm and is located at a distance of 16 cm from the proximal magnet.
  • Fig 22 is a zoom about the peaks of the pulses illustrated in Fig. 21.
  • “A” and “B are the pulses measured by proximal and distal magnet, respectively.
  • test data (Teflon tube diameter) was measured using the MMS which used as a demonstration device. By using Medical Ultrasound systems or other well-developed systems the result will be more accurate.

Abstract

The invention discloses a method, and devices for determining volume flow, blood velocity profile, artery wall properties of a tubular conduit system, stenosis identification and localization by introducing an artificial pressure (5) or flow excitation signal (a single signal or multiple signals) into the blood vessel (2) (or in any other tubular flowing fluid conduits), and or using natural heart beat signals measurement and analysis of the vessel wall displacements or vessel diameter changes.

Description

A SYSTEM AND METHOD FOR DETECTION AND CHARACTERIZATION
OF STENOSIS, BLOOD VESSELS FLOW AND VESSEL WALLS
PROPERTIES USING VESSEL GEOMETRICAL MEASUREMENTS
FIELD OF INVENTION
The present invention relates to the field of medical diagnostic and therapeutic devices for characterization of blood vessel lesions and properties using invasive and noninvasive measurements.
BACKGROUND OF THE INVENTION
Vascular diseases are often manifested by reduced blood flow due to atherosclerotic occlusion of vessels. For example, occlusion of the coronary arteries supplying blood to the heart muscle is a major cause of heart disease. Invasive procedures for relieving arterial blockage such as bypass surgery and balloon dilatation with a catheter are currently performed relying on estimates of the occlusion characteristics and the blood flow through the occluded artery. These estimates are based on measurements of occlusion size and / or blood flow. Unfortunately, current methods of occlusion size and blood flow measurement have low resolution, are inaccurate, are time consuming, require expertise in the interpretation of the results and are expensive. Thus, decisions on whether or not to use any of the blockage relieving methods and which of the methods should be used, are often based on partial information. The evaluation of therapeutic success is also problematic, where both occlusion opening and stent position have to be evaluated.
Pressure, flow and geometry are three variables often measured in the cardiovascular system. Recent progress in probe miniaturization, improvements of the frequency response of probe sensors and computerized processing have opened a whole new range of pressure, flow and geometrical measurements that have been previously impossible to perform. Typically, the physician first selects the appropriate treatment method from among medication therapy, transcatheter cardiovascular therapeutics (TCT), coronary artery bypass grafting (CABG), or non-treatment. Atherosclerotic lesions may have different characteristics. Some lesions exhibit a variable degree of calcification while others have a fatty or thrombotic nature. Lesion characteristics together with vessel condition proximal and distal to the lesion are the major factors for determining the therapeutic procedure needed. Recently, increasing numbers of patients have been directed toward TCT. TCT starts with an interventional diagnosis procedure (angiography), followed by the treatment of the patient with medication therapy. CABG or continuation of the TCT procedure with adequate interventional treatment.
Numerous methods are currently available for treating various lesion types. Some of these methods which are sequenced from "softer" to "heavier", relating to their ability to open calcified lesions are as follows; percutaneous transluminal angioplasty (PTCA), "Cutting balloon" angioplasty, directional coronary atherectomy (DC A), rotational coronary atherectomy (RCA), Ultrasonic breaking catheter angioplasty, transluminal extraction catheter (TEC) atherectomy, Rotablator atherectomy, and excimer laser angioplasty (ELCA ). Often, stents are placed within the lesion so as to prevent re-closure of the vessel (also known as recoil). If the stent is malpositioned, it interrupts the flow and may initiate restenosis.
Lesion characteristics, together with vessel condition proximal and distal to the lesion, are used to determine the medically and economically optimal treatment method or combination of methods of choice. Angiography has been the main diagnostic tool in the catheter laboratory. The physician uses the angiographical images in order to identify and locate the lesions, evaluate the occlusion level (percentage of normal diameter) and qualitatively estimate the perfusion according to "thrombolysis in myocardial infarction" (TIMI) grades, determined according to the contrast material appearance. TIMI grades 0,1,2,3 represent no perfusion, minimal perfusion, partial perfusion and complete perfusion, respectively. Among the more sophisticated diagnostic tools are qualitative coronary angiography (QCA), intravascular ultrasound (IVUS) intravascular Doppler velocity sensor (IDVS) and intravascular pressure sensor (IPS). QCA calculates geometrical properties from angiographic images, in image zones that are chosen by the physician.
IVUS provides accurate geometrical data regarding cross section area and accurate information regarding the vessel wall structure and composition. IDVS provides velocity measurements, enabling discriminating various degrees of occlusion according to coronary flow reserve (CFR) criteria. IDVS suffers from inaccuracy problems resulting from positioning errors within the vessel. IPS provides pressure measurements enabling discriminating various degrees of occlusion according to the FFR (fractional flow reserve) criteria. Angiography and the sophisticated techniques discussed above may be employed prior to and after the therapeutic procedure (the last for the evaluation of the results and decision about correcting actions). Among the noninvasive diagnostic devices for blood flow rate and vessel walls properties there exists an apparatus named "Vascular Echo Doppler" developed at the "Institute of fundamental Technological Research-Polish Academy of Sciences" Swietokrzyska 21, 00-049 Warsaw, Poland.
The device is used for Noninvasive Examination of Input Vascular Impedance, elasticity of Arterial Walls and volumetric blood flow. (Impedance is defined here as the ratio between blood pressure and blood flow in the linear approximation of blood flow). The apparatus is claimed to be a computerized Ultrasonic system consisting of a double ultrasonic probe locates at the same position along the artery. Both probes operate simultaneously, the first probe in the Echo-mode measures instantaneous vessel diameter and the second probe is in a CW-Doppler mode and measures blood flow (i.e., blood velocity). Being a single position probe, elasticity of the artery cannot be calculated by vessel diameter alone. It is claimed that it is possible to infer systolic and diastolic pressure in other parts of the body (e.g. common carotid) from pressure measurements in the brachial artery. (Pol et al., 1994). Assuming this correlation always valid, pressure and vessel diameter are known at the same location, thereby giving the value of the compliance or distensibility at the same location. The need for extraneous pressure measurement is a disadvantage since the use of the brachial pressure curve might not be useful for distant or small arteries (Nichols and O'Rourke, 1998 chapter 8).
SUMMARY OF THE INVENTION The invention discloses a method and devices for determining volume flow, blood velocity profile, artery wall properties of a tubular conduit system and stenosis identification and localization by introducing an artificial pressure or flow excitation signal (a single signal or multiple signals) into the blood vessel (or in any other tubular flowing fluid conduits), and or using natural heart beat signals measurement and analysis of the vessel wall displacements or vessel diameter changes.
This invention provides an apparatus, and system for determining volume flow, blood velocity profile, and/or artery wall properties of a tubular conduit system and stenosis identification and localization, said apparatus comprising: a means for generating an artificial pressure signal or an artificial pressure wave velocity; a means for measuring artery diameter or displacement resulting from said artificial pressure signal or an artificial pressure wave velocity or using natural heart beat signals; a processor unit operatively connected to said measuring means; a program for controlling the processor unit, wherein said processor unit is operative with said program to receive said signal which is represented of the measure of said artery diameter or displacement resulting from said artificial pressure signal or an artificial pressure wave velocity or using natural heart beat signals and determine volume flow, blood velocity profile, and/or artery wall properties from analysis of the vessel wall displacements or vessel diameter changes.
In one embodiment the processor unit is operative to select a method from a plurality of methods to generate artificial pressure signal or an artificial pressure wave velocity or using natural heart beat signals. In another embodiment, the tubular conduit system is a blood vessel system and said processor unit is operative to detect changes in arterial characteristics. In another embodiment, the processor unit is operative to determine volume flow. In another embodiment, the processor unit is operative to detect stenosis. In another embodiment, the processor unit is operative to determine blood velocity profile.
In one embodiment, the measuring means is by ultrasound or magnetic motion sensor. In another embodiment, the measuring means is by ultrasound. In another embodiment, the measuring means is by magnetic motion sensor. In another embodiment, the means for generating a pressure signal is in by a non-invasive means. In another embodiment, the means for generating a pressure signal is by an exciter. In another embodiment, the non-invasive means for generating a comprises a mechanical and/or electrical means. In another embodiment, the mechanical non-invasive means for generating a comprises applying pressure to the carotid.
In one embodiment, the signal is a plurality of discrete signals said processor unit is operative to sample said discrete signals and receive pressure wave velocity data. In another embodiment, the processor unit is operative to perform a single pressure function using said discrete signals and said pressure wave velocity data.
This invention provides a method for determining volume flow, blood velocity profile, and/or artery wall properties of a tubular conduit system and stenosis localization, comprising: generating an artificial pressure signal or an artificial pressure wave velocity or using natural heart beat signals; and measuring artery diameter or displacement resulting from said artificial pressure signal or an artificial pressure wave velocity; thereby determining volume flow, blood velocity profile, and/or artery wall properties of a tubular conduit system.
In one embodiment the processor unit is operative to select a method from a plurality of methods to generate artificial pressure signal or an artificial pressure wave velocity. In another embodiment, the tubular conduit system is a blood vessel system and said processor unit is operative to detect changes in arterial characteristics. In another embodiment, the processor unit is operative to determine volume flow. In another embodiment, the processor unit is operative to detect stenosis. In another embodiment, the processor unit is operative to determine blood velocity profile.
In one embodiment, the measuring means is by ultrasound or magnetic motion sensor. In another embodiment, the measuring means is by ultrasound. In another embodiment, the measuring means is by magnetic motion sensor. In another embodiment, the means for generating a pressure signal is in by a non-invasive means. In another embodiment, the means for generating a pressure signal is by an exciter. In another embodiment, the non-invasive means for generating a comprises a mechanical and/or electrical means. In another embodiment, the mechanical non-invasive means for generating a comprises applying pressure to the carotid.
In one embodiment, the signal is a plurality of discrete signals said processor unit is operative to sample said discrete signals and receive pressure wave velocity data. In another embodiment, the processor unit is operative to perform a single pressure function using said discrete signals and said pressure wave velocity data.
This invention provides a method of determining the geometrical shape of the stenosis. Such determination as provided for herein is determined by comparing the pressure signal proximal to the stenosis to the pressure signal distal to the stenosis so as determine the geometrical shape of the stenosis. In another embodiment the reflection method as disclosed herein is determined and then based on the reflection the geometrical shape of the stenosis is determined.
This invention provides a method and devices may also serve for evaluating the success of medical treatment. For example tracking sufficient opening for determining volume flow, blood velocity profile, and/or artery wall properties of a tubular conduit system occlusion or malpositioning of a stent. It may also serve for the characterization of vascular bed, downstream the vessel. The present invention provides a method for further analysis of the response to the excitation signal yielding a quantitative determination of elastic properties of blood vessel walls for characterizing, wter alia, the distensibility and the compliance of lesioned and non-lesioned parts of blood vessels. The derived elastic properties may be further used to determine the degree of calcification of lesioned and non-lesioned parts of blood vessels.
BRIEF DESCRIPTION OF THE DRAWINGS The present invention will be understood and appreciated more fully from the following detailed description taken in conjunction with the appended drawings in which like components are designated by like reference numerals:
Figure 1 illustrates an ultrasound measuring system for measuring vessel wall displacements or vessel diameter changes caused by heartbeats pressure signals.
Figure 2 illustrates an ultrasound measuring system for measuring vessel wall displacements or vessel diameter changes caused by artificial pressure signals
Figure 3 illustrates an exciter use for generating artificial pressure signal inside a blood vessel.
Figure 4 illustrates an in vitro test apparatus used to verify the analytical results
Figure 5 is a zoom on part of the in vitro test apparatus illustrated in Fig. 4.
Figure 6 is a schematic description of the in vitro test apparatus.
Figure 7 illustrates the Magnetic Motion Sensor incorporated within the in vitro test apparatus and used to measure tube wall displacements caused by pressure signal. Figure 8 illustrate the MMS together with the in vitro test apparatus.
Figure 9 illustrates the test set up used in the experiment for flow determination.
Figure 10 illustrates an in vitro test performed in order to determined the distensibility of the latex tube.
Figure 1 1 illustrates the results of the in vitro test for determining the distensibility of the latex tube.
Figure 12 illustrates test results of pressure measurements versus MMS output voltage.
Figure 13 illustrates the pulses measured by the MMS in experiment for determining pressure wave velocity.
Figure 14 is a graph illustrating comparison of the volume flow rate as a function of time as computed using model 2 and the flow as obtain from flow meter measurements.
Figure 15 is a graph illustrating the tube wall shear stress as a function of time as calculated from data obtained from two experiments with different flow rate.
Figure 16 illustrates flow axial velocity profile as calculated from the data obtained from an in vitro test.
Figure 17 is a plot of computed axial centerline velocity using model 1.
Figure 18 is a graph illustrating comparison of the volume flow rate as a function of time as computed using model 1 and the flow as obtain from flow meter measurements.
Figure 19 illustrates comparison between the flow calculated from model 1 and 2for two different flow rates. Figure 20 illustrates a test setup for identifying and localizing stenosis.
Figure 21 is a plot of the proximal and distal signal measured by the MMS in an in vitro test for identifying and localizing of a stenosis.
Figure 22 is a zoom on the peaks of the pulses illustrated in Fig. 21.
DETAILED DESCRIPTION OF THE INVENTION The present invention gives a method for deducing the volume flow rate, velocity profile, properties of artery walls (compliance and distensibility) and stenosis detection and localization. The method uses measurement of blood vessel cross section area (or diameter if the artery is quasi-circular) as a function of time. Then pressure and pressure wave velocity are derived from vessel area (or diameter) measurements enabling the determination of flow, wall properties and stenosis location. The method is designed to serve as a diagnostic tool for the physician when emphasis is put on optimizing measurement duration, computer resources and data processing time.
Arteries distend during systole and store volume energy during this phase of the cardiac cycle thereby limiting the increase in blood pressure. The local area of the artery, at a point x is a function of time A(x,t) directly dependent on the Pressure pulse. It has been established that distension is practically normal to the axis of the artery since longitudinal motion is strongly hindered (strong tethering), and that pressure is constant in a cross-section so that pressure is a function of x and t alone. Also the local instantaneous area is a function of the instantaneous local pressure which in mathematical terms can be written as A(x,t)=f(P(x,t)); the function f determining the elastic properties of the artery (f is monotonically increasing). Several forms have been proposed for f that will be described herein below. Thus, knowing the area A(x,t), or diameter, D(x,t), is equivalent to knowing pressure. In an elastic tube, there are two agencies for driving the flow. One is the pressure gradient (when pressure is transversally constant) and the other is the pulsatile motion of the tube, which acts on the fluid through the no-slip condition enforcing zero fluid velocity (axial, radial and circumferential) at the wall. Hence, by measuring areas and pressures at Nx points x, i=l ...Nx along a short segment of an artery of length L, at time intervals t+jTs j=0...Nτ for at least one cardiac cycle, thereby producing a matrix A(x,,tj), it is possible to reconstruct with reasonable accuracy the relevant flow and wall elastic properties..
Flow, stenosis location and vessel wall properties are computed from geometrical measurements of blood vessel (wall displacement or artery diameter). Vessel diameter is measured using an ultrasound device or any other noninvasive device as for example described below. If an ultrasound apparatus is used, it must have a probe with at least two ultrasound lines at two different neighboring locations with known distance between them. The probe operates the two lines simultaneously in Echo-mode and measures vessel diameter. Pressure is derived from diameter measurements. The data is processed to yield two diameters which are functions of time.
Reference is now made to Fig. 1 illustrating the measuring system. An ultrasound-measuring device (1) is attached to a processor unit (3) and measures changes in blood vessel diameter (2) as a function of time. The changes in diameter are due to pressure pulses caused by heartbeats. Measurements are performed at two neighboring points. A stenosis (4) might be present, distally, in which case it will be detected. From these geometrical measured data, flow, stenosis location (if present) and artery wall properties are computed.
In another embodiment the displacements of artery walls may be determined using more than two measuring points along the artery. In such a case P(x,t) is derived from the multi number of measurements. In another embodiment the displacements of artery walls may be determined using ultrasound measurement of a single artery section. In such case, a second measurement of another section, located at a known distant from first section is performed later. Then time synchronization of the measured results has to be performed.
In another embodiment the displacements of artery walls may be determined using Magnetic Motion Sensor (MMS) which measures the vessel wall displacements. Such a device capable of measuring wall displacements of latex tube is incorporated within an in vitro test system. The laboratory MMS device is illustrated in Figs 7 and 8. A device, based on the same principles, may be adjusted for clinical purposes and used for measuring vessel wall displacements. This is possible in cases of arteries located close enough to the body external skin, such as the carotid.
In another embodiment an exciter (a short duration pulses generator) may be used. Reference is now made to Fig. 2 illustrating this embodiment. The exciter (5) generates an artificial pressure pulse that propagates along the vessel. The pressure pulse is introduced into the vessel by a catheter (6). The changes in vessel diameter (2) caused by the excited pressure signal going forward and the reflected signal coming backward from a stenosis (4) are measured by an ultrasound device (1). The changes in diameter are better detected and measured than those caused by heartbeats. This improves the accuracy of measurements and results.
Reference is now made to Fig. 3 demonstrating such an exciter. The exciter is a device for the excitation of the pressure waves inside the tube (catheter). It consists of a hammer (7) and conical chamber (8). Low voltage is applied to the solenoid (not shown) that pushes the weight (hammer). This weight strikes the membrane (9) of the conical chamber thus initiating a short pressure pulse. The opening of the cone is connected to a catheter (6). In the initial state the chamber and the catheter are filled with the fluid. The movement of the membrane is allowed only in one direction, so only positive pressure pulse is produced. The membrane returns to its initial position by the effect of a spring. Displacement of the membrane and pressure wave generation could be achieved as well by using an actuator based on piezoelement or other pressure generating device.
In one embodiment, the methods provided herein are based on introducing an artificial pressure signal into the blood vessel. In one embodiment the pressure signal originates from a pressure signal generator (PSG). For example, a PSG of the type suitable for this purpose is a "blood pressure systems calibrator" model 601 A, commercially available from Bio-Tek Instruments Inc., Highland Park, Box 998, Winooski, VT-05404-0998, U.S.A. Catheterization laboratory injection systems are known to those skilled in the art. For example, a system of the type suitable for this purpose is a "Mark V Plus Injection System" from Medrad, inc. 271 Kappa Drive, Pittsburgh,PA 15238-2870 U.S.A. Other examples include but are not limited to the following: a pressure signal generated within the catheter or in its distal tip (e.g. piezoelectrically or by another form of energy burst introduction e.g. AcolysisSystem, ultrasound thrombolysis selective lysis of fibrin, by Angiosonics Inc., NC, U.S.A.); is by the movement of an hydrodynamic surface, activated either manually or by a special mechanism (e.g catheter used for removing malpositioned or embolized stents, for example Amplatz Goose Neck Snare GN 500 and Microsnare SK200 from Microvena corporation, Minnesota USA and catheters which prevent plaque debris from moving downstream); a pressure signal caused by an external controlled pressure applied on an organ, transmitted into a pressure signal within the vessel; a pressure signal caused by a non-invasive energy transmission into the vessel (e.g. ultrasound) in which the artificial pressure/flow signal may be either controlled or measured (within the catheter or the vessel).
In one embodiment, the methods provided herein are based on using natural heart beat signals measurement and analysis of the vessel wall displacements or vessel diameter changes.
In another embodiment the signal generator is a pressure signal generator; said signal sensor is a pressure signal sensor; and said processor unit is operative to receive a heart beat signal; and synchronize receipt of said probe signal with said heart beat signal. As contemplated herein, the signal sensor includes at least two sensing transducers disposed in spaced apart relation. The signal sensor is movable between at least two positions relative to said tubular conduit system and said processor unit is operative to calculate a pressure wave velocity from signals received from said two positions. In another embodiment the signal sensor includes a signal conditioner. The signal may be derived from either one of the internally generated waveforms or excited electronically from a separate signal generator either a stand alone unit. A stand alone unit is of the type suitable is a multifunction synthesizer model HP8904A from HP Test and measurement Organization, a Hewlett Packard company USA) or integrated within a system computer, otherwise used for data acquisition and analysis. For example, an electric impulse generator is shown in Figure 29.
In another embodiment the pressure signal may originate from an impact mechanism system. Such impact mechanisms are known to those skilled in the art. For example, the impact mechanisms may be of the spring loaded or electronically activated mechanical impact system types, applying pressure on either the catheter or on a container attached to it. A signal generation apparatus (in vitro and in vivo) of the impact mechanism type makes use of a pistol hammer mechanism, where the pistol hammer hits directly on the catheter, lying on a rigid surface. The pistol used was a P230 semiautomatic pistol from Sig Sauer, Switzwerland. Alternatively, the same pistol hammer hit the head of a standard 5 ml syringe, where the syringe was connected to the catheter through a standard manifold.
The artificial pressure flow signal may also be synchronized with heart beats, either by gating to ECG or to system measurements (pressure or flow) in which the ECG device measures heart heat signals upon reaching a desired time in the heart beat triggering the artificial pressure flow signal. The pressure signal advances through a catheter lumen into the blood vessel. The catheter may be a guiding catheter. A guiding catheter of the type suitable for this purpose is a 8F Archer coronary guiding catheter from Medtronic Interventional Vascular, Minneapolis, U.S.A.. A diagnostic catheter of the type suitable for this purpose is a Siteseer diagnostic catheter, from Bard Cardiology. U.S.A. A balloon catheter of the type suitable for this purpose is a Supreme fasr exchange PTCA catheter, by Biotronik GMBH & Co, U.S.A. It should be noted that almost any type of hollow catheter may be used. The presence of occlusion or aneurysm downstream creates reflection of pressure and flow waves. By extracting data of the reflected pressure waves, originated in the occluded site, the location and degree of occlusion can be determined using signal processing methods.
The performance of pressure wave velocity and reflection site parameters (position and reflection coefficient) estimation is based on two-point pressure measurement carried out inside of an artery. The pressure is measured either simultaneously by two pressure sensors or in different time by single sensor with some additional synchronization mechanism. In the case of the simultaneously pressure measurement two pressure sensors are placed throw known distance d. In the single sensor case the pressure is firstly measured in point a (upstream) and after that - in point b (downstream).
Computation of Pressure Wave Velocity (PWV:
There are several methods for computing the PWV. One of the most usual and noninvasive methods is to compute the time, Δt, between arrivals of the area or diameter pulse between two positions at distance L apart. The PWV is then equal to PWV = L/Δt. In order to isolate the part of the incoming pulse, without contributions of the reflected pulse the foot of the pulse at systole is considered.
Compliance and Distensibility: Compliance and distensibility are related to Pressure Wave Velocity as follows:
Consider an element of volume dV= A .dl of length dl and cross-section area A in which the instantaneous pressure equals P. Then compliance, C, is defined as the derivative of the volume with respect to pressure per unit of length:
\ dV \A*dl+dM dA
I dP I dP dP (i) since arteries are strongly axially tethered. Distensibility, Dst, is the relative change of the area with respect to pressure:
1 dA
Dst
A dP (2)
and the compliance is:
C=A« Dst (2-1)
The pressure velocity c is related to the measured Pressure wave velocity (PWV) through:
c=PWV-u (3)
Where u is the blood velocity in the artery. Since u is of the order 30 cm/s or less, and c is 7 m/s, we may ignore the distinction between c and PWV (but should be kept in mind if higher accuracy is needed) so that c=PWV (3-1) In the present invention the measured parameter is the inner diameter D. Assuming a circular vessel diameter measurement is equivalent to area measurement since A = π.D 14 and
2 dD Dst
D dP (4)
The obvious way to calculate the elastic properties of the artery is to measure the diameter as function of pressure. In the absence of any pressure measurements, the distensibility is calculated tlirough the measurement of the Pressure Wave Velocity using the relation (p is the blood density): 1 c p*Dst (5)
If one assumes a constant distensibility, then integrating Eq.(2) yields:
A(P(x, Q)
P(x, t) = P0 + pc2 log
A0(x) (6)
where Ao is the area corresponding to an internal reference pressure Po. Human arteries are stiffer at higher pressure. Several empirical models have been proposed and may be used for more accurate results.
For example, Streeter et al. (1963) consider the artery as a thin-walled vessel made of incompressible elastic material (Poisson's ratio = 0.5) and derived the theoretical expression
Figure imgf000018_0001
where ho and Do are the wall thickness and arterial diameter at reference pressure Po, respectively and E is the effective elastic modulus. A popular model is the one of Langewouters et al., (1984) using an arctangent function and three optimal fit parameters:
Figure imgf000018_0002
The difficulty with these formulae is in the determination of the parameters. It appears that Eq.(6) is in error for systolic pressures. Since these large pressure last for but a small fraction of the cardiac cycle, the error in the dynamics is not significant. If one desires a more accurate result, the calibration of the parameters should be carried out concurrently to the measurement. It is easy to incorporate artery stiffening in the fluid dynamical algorithm presented below.
In arteries, pressure is an almost periodic function. During the short measurement time pressure is quasi periodic. Therefore the minimal value of the pressure exhibits very small variations. Therefore it is legitimate to take as the reference pressure Po the minimum of the pressure in an cardiac cycle, i.e., the diastolic pressure. The corresponding area at position x is thus An(x). When the PWV can be measured at several points along a cardiac cycle thereby obtaining a good approximation (by numerical interpolation) to the function c(A) where A varies between diastolic to systolic Area. Then formula (5) can be generalized to
Figure imgf000019_0001
and upon inverting the latter formula Eq.(6) now reads
Figure imgf000019_0002
In case the artery can be considered circular the latter formula is replaced by
Figure imgf000019_0003
Blood Rheology:
In large arteries, blood can be modeled as a Newtonian fluid (Y.C Fung , chapter 3)
Figure imgf000020_0001
(9) where v is the velocity vector, τ the stress tensor and V the shear rate tensor. The symbol p is the pressure field and μ = 0.0036-0.0040 the coefficient of viscosity which depends on the hematocrit. However, for sufficiently small shear rate blood is no longer Newtonian. A reasonable model incorporating the high and low shear rate is Casson's model. The effect of the non-Newtonian behavior is mainly felt in regions of low shear which are mainly in the center of the artery. The total effect of the non-Newtonian model is to make the velocity profile blunter than otherwise. Near the wall, the shear rate is large so that the fluid is Newtonian there. In this invention the blood is modeled as a fully Newtonian fluid, although its non-Newtonian behavior can be incorporated, as well.
Model 1 : Transversally averaged Fluid Dynamics Equations:
This model is a quasi-linear model in which the fluid dynamical equations are integrated over the cross section. It is especially useful for arteries in which the cross-section is manifestly non-circular. In effect it transforms the full three dimensional flow equation to one-dimensional ones in the couple Q and P where Q(x,t) is the volume flow rate or alternatively A and Q since A and P are related through compliance. The price of such a drastic simplification is the introduction of empirical constants. Fortunately, these constants have a small effect so that they need not be known with great accuracy.
The basic equations are the continuity and momentum equations (Navier-Stokes). It is convenient to use cylindrical coordinate where x is the axial coordinate along the tube, r is the radial coordinate and θ is the circumferential angle. Basic Equations: » Continuity Equation:
1_ +, ! dvt dV.
+ = 0 r dr r dθ dx (10)
* Axial component of the momentum equation
(Δ is the Laplacian, p is the pressure, μ is the blood viscosity and p is the blood density ):
Figure imgf000021_0001
The momentum equation is simplified by making the long wavelength approximation co R
« 1 where ω is the angular velocity, R is the radius (or an average transverse
dimension) and c is the wave velocity. It follows that the axial viscous transport term is negligible and pressure is constant throughout a cross-section. The momentum equation reads then:
Figure imgf000021_0002
Our interest is in the flow (i.e. the volume flux), Q(x,t) which is the volume of blood crossing a point x at time t. Clearly,
Figure imgf000021_0003
cro sss - s e c tio n
It should be emphasize that we are not interested in the velocity field but in the integrated field over a cross-section. First, the continuity equation is integrated over the cross-section at point x:
(14) cross
Figure imgf000021_0004
The first integral over r is trivial and one obtains:
cross— J7 section
Figure imgf000022_0001
(15) where R(θ) is the radial distance of the boundary to the center of the tube at angle θ and A(x,t) is the cross-section area at point x at time t. The second integral vanishes identically (upon performing the angular integral, first) and the third integral yields:
d x cross
Figure imgf000022_0002
(16)
All in all, the continuity equation becomes:
Figure imgf000022_0003
Next, the continuity equation (Eq.lO) is multiplied by Vx and then add the momentum equation (Eq.12) obtaining:
Figure imgf000022_0004
and upon integrating the latter equation, one obtains:
£__ + _ __. (!v drdθ = _l E + E θ)£ . δt δx cross- Jse ti *on p ' δx p ' perim leter ' dr (19) Without loss of generality, one can define a parameter β (x, t) such that:
jjV/rdrdθ = β(x,t)£&l (20) cross-sec tion \ ' /
The parameter β varies between 1 for a blunt velocity profile and 4/3 for a parabolic velocity profile. In arteries it is observed that β is very close to one. In addition, the quadratic term is very small, except possibly at severe constrictions (stenoses). The integral on the r.h.s. represents the force exerted by the wall on the fluid. The wall shear stress (WSS) conventionally denoted by τ having dimensions of a pressure is defined as:
Figure imgf000023_0001
The Momentum equation finally reads:
Figure imgf000023_0002
Eqs (17) and (22) are the one-dimensional equations for A and Q in the long-wave-length approximation. Clearly, by ignoring the quadratic term in Q and the stress one recovers the well-known linear model. It remains to find an appropriate model for the WSS as well as ?. As is often the case in fluid dynamics, empirical parameters must be adjusted for the specific application at hand. Nevertheless, choosing β = 1 introduces a negligible error.
The pressure drop in a pulsatile flow is mainly due to both viscous effects and to a pressure force for flow acceleration. The PoiseuiUe WSS for a steady flow is 8πμ proportional to - Q whereas the inertial force is proportional to the time derivative pA of Q.
According to Young and Tsai (1974), the following expression is the preferred one:
Figure imgf000023_0003
The coefficients cu and cv are slowly varying coefficients depending on the Womersley number: ω p a R (24) μ The first term in the stress expression is the usual PoiseuiUe stress and the second one is an unsteady contribution. In the aorta c, » 1.1 and cu » 1.6. For each type of artery (e.g. carotid) a computational and clinical study should yield an optimal set of coefficients.
Area-Pressure Relation:
Figure imgf000024_0001
Compliance and distensibility are explicit functions of x.
The Hyperbolic System:
It is more convenient (although not mandatory) to use variables P and Q. Clearly, dA dP dQ
+ = 0 (26) dP dt dx and using (Eq 25) the continuity equation becomes :
1 df dP dQ
+ 0
A0 dP dt dx (27)
The second equation is obtained using the substitution in Eq.(22):
Figure imgf000024_0002
one obtains the second equation
Figure imgf000024_0003
Figure imgf000024_0004
(A in the latter equation stands for f(P)Ao so that A can be fully eliminated) (Stergiopulos et al. 1992).
Initial Conditions:
The initial value of A as well as Q must be specified (i.e. A(x,0) and Q(x,0) for all x in the segment [0,L] ). The difficulty resides in the absence of datum concerning the initial flow. However, since the system is periodic, the initial conditions rapidly die off. The system of equations is run with arbitrary initial conditions (e.g., zero flow) with repeating the datum for a few periods (up to ten periods, typically) until the system settles in the periodic regime.
Model 2: Axisymmetric Flow Equations:
When flow is axisymmetric, and in the absence of swirl, VQ = 0, the axial momentum d2Vr . equation (the term is neglected in the long wave-length approximation) reads dx1
^ cW + V ^ dZVJ + V dV l a P μ d 1 W a r dr x dx p d x p 3r r 3" (30)
and the continuity equation 1 3(r Vr ) cV
+ = 0 r dr dx (31)
together with the elasticity equation R (t, x )
= (P - PQ ) (32)
R, dα
Note that D - 2 — (R0) and C = (pD)"1/2. The boundary conditions are assuming no slip dp at the wall and axisymmetric flow: d V. i. = o , Vr = 0 at r = 0 d r vx = o at r = R(t,x) r dt '
Where t denotes time, P the pressure, P0 mean pressure. Now, we define the transverse coordinate ξ= r/R(t,x) with the property that ξ = 1 on the boundary. Next, by non-dimensionalizing the equations and using the non-dimensional variables: τ = cot, z = ωx/C , w = Vx /C , u = Vx /ωR0 , p = (P - Po)/pC2 and the Womersley
1 1*) parameter α = Ro (ω p/μ) and ω is the angular frequency. Finally, after tedious but straightforward algebra Eq.(33) is obtained:
Figure imgf000026_0001
1 d ( \ dw „ d \n a dw \ξu) + ξ -' (33) aξ dξ h dz h dz dξ
and a = a(p). The boundary conditions assume the much simpler form: d w
= 0 . u = 0, at ξ = 0 d ξ da w = 0 u = — , at ξ = 1 dt
The system simplifies considerably by noting that upon integrating the second equation over ξ from 0 to ξ (after multiplying by ξ):
U a d ξ dz dξ ξ dz (34)
the radial component of the velocity is an explicit function of the axial component. dw Because of the term — the equations require the knowledge of the axial velocity at both dz ends of the vessel. Since the axial velocity profile does not vary significantly in the axial direction, a natural approach is to attempt a solution in powers of the axial variable z: w(z,ξ,τ) = w0(ξ, τ) + zwx (ξ,τ) + z2w2(ξ, τ) + ... (35a) u(z,ξ,τ) = u0(ξ,τ) + zu(ξ,τ) + z2u2(ξ,τ) + ... (35b) a(z,ξ,τ) = a0(ξ,τ) + zax(ξ,τ) + z2a2(ξ,τ) + ... . (35c)
+ z2g2(ξ,τ) + ... (35d)
Figure imgf000027_0001
Since the equations are non-linear, the order n terms depends on the term of order n+1. Normally one cuts the hierarchy at some low order (the closure problem) and oftentimes the scheme yields a good approximation (a known counter-example is turbulence). It is sufficient to assume a linear tapering on the measured segment. The continuity equation decomposes into two equations:
Figure imgf000027_0002
dw u (ξ,r)= λ ) ξ a. dξ'~— f ξ'awdξ' (36b) ξ dξ
The axial equation becomes to zeroth order in z ( Eq37a):
Figure imgf000027_0003
and to first order in z (Eq37b)
Figure imgf000027_0004
The extra complication comes from the tapering term aj. No Tapering:
Model 2 relates to a generalized case where the artery is with or without tapering. The case of no tapering is a simplified case of model 2.
It is simpler to return to the dimensional variables (Johnson et al. 1992). To linear order in x:
Vx(r,x,t) =f0(r,t)+xfx(r,t) (38a) dP(z, t)
= G0 (t) + xG (t) (38b) dx
The continuity equation reads:
\ d(r Vr )
+ /, = 0 (39)
3"
Introducing a stream function solves the continuity equation
r (40)
and
- 1 dψ
(41) r dr
The two axial equations read:
Figure imgf000028_0001
and
Figure imgf000028_0002
where d 1 dΨ h ≡ dr r dr (44)
The boundary conditions are along the centerline
Figure imgf000029_0001
and along the wall r= R(t) (no tapering): ψ(R(t),t) = R(t) * u(R(t),t) (46b)
Figure imgf000029_0002
the flow is calculated using the following equation:
Figure imgf000029_0003
Preparing the Pressure Signals for Numerical Computation:
1. The minimal areas at the Nx positions are recorded by selecting the minimal area in time at each of those positions.
2. Pressure signals are computed according to the compliance model. For example: from the formula in the constant distensibility mode one obtains the Nx signals:
A ( xt , t , )
P { x t . ) = PQ + pc 2 log (48)
3. From the Nx values of (x, , t, ) , NT inteφolating polynomial of order Nx-1, Pc, (x) are constructed through the Nλ positions points on the measured segment. This is necessary for solving the numerical equations by finite differences or finite elements. For example, in the case of two measuring points x and Xi+L Pix^-Pi^+JL^tj)
Pci(x) = P(xx,ti) (x-xx) (49)
and the pressure gradient is inteφolated as:
dP P(x],tJ)- P(xl + L,tp (50) dx L
and for three measuring points xi and x2 and x3
Figure imgf000030_0001
the pressure gradient is dP ( - + x3 )P(x, , t ) (x, + x3 )R(x2 , t ) (x, + x2 )R(x3 , t )
— = — + — + — dx (x, -x2)(x, -x3) (x2 -Xj)(x2 -x3) (x3 -x,)(x3 -x2)
Figure imgf000030_0002
Detection and Localization of a Downstream Stenosis: The non invasive sensors measure diameters and upon using the Pressure- Area (or diameter) relation the pressure signal are obtained. Assuming that the linear wave theory is valid and that the supeφosition principle is applicable, the pressure wave can be linearly decomposed into a forward moving and backward moving wave, Pf(x,t) and Pb(x,t) , respectively. Hence, the pressure wave is a sum of a forward and backward moving wave:
P(x, t) = Pf (x, t) + Pb (x, t) (53)
For a forward wave (propagating in the direction of the flow:
Pf(x,t) = Pf(θ,t-x/c) (54)
Fourier transforming the function Pf{0,t):
Figure imgf000031_0001
from Eq.(54)
+oo
- jω
Pf(x,t) = ϊe [ c(ω)}Pf(ω)dω
(56)
00 In order to incoφorate attenuation, a function CC(ω) (complex c) is introduced: 1 1
+ j Att(ω) . (57)
CC (ω) c(ω) the real part and the imaginary part of 1/CC being the inverse of the PWV and the attenuation of the wave. Therefore
Figure imgf000031_0002
The PWV is practically constant for frequencies except for the first few harmonics. Also attenuation vanishes at zero frequency and can be estimated by keeping the linear term in a series expansion of the attenuation function, that is: Att(ω) = αω where α is the attenuation coefficient. The backward wave originates from reflection of the forward wave at the stenosis and in the linear approximation the forward wave of angular frequency ω yields a reflected wave of the same frequency multiplied by a (complex) reflection coefficient R(ω) so that :
Pb{ω ) = R {ω ) - P ff ( Vω22)</ (59) WO 00/55579 PCTtlLOO/00172
The dependence of the reflection coefficient on the frequency is very weak in the range of physiological pulses and can be ignored so that R(ω) « R.
Let the proximal and distal sensors have coordinate "0" and "Z", respectively. The backward wave at a given sensor is equal to R times the path from the sensor to the stenosis and back; the path equals 2L for the proximal sensor and (2L-Z) for the distal sensor. Hence:
+∞ 2 ωL j CC (ω) (o, = { 1 + R -e P ff{ω)e~jωtdω (60)
.lω(L-Z) ωZ j-
\ + R-e CC(ω) e CC{ω)PAω)e-jωtd ω (61)
Let F(ω) and G(ω) denote the Fourier transforms of P(0,t) and P(Z,t), respectively. They are equal to the expressions multiplying exp(-jωt) under the integral sign. Upon dividing F(ω) by G(ω) it follows that:
.lω(L-Z)
G(ω) _ 1 + R-e ] CC(ω) ωZ
J
CC (ω) F(ω) ~ 2ωL
(62) l + R-e CC(ω)
Thus the ratio of the Fourier transforms of the proximal and distal pressure pulses is a known function of ω, R, L and Z and CC(ω). Clearly, Z, the distance between probes is known. In addition, the PWV can be computed using the method described here in above. There remain, three parameters R, L (the distance to the stenosis) and the attenuation coefficient, α. To be computed. In practice, a least-square fit procedure is the easiest method, as shown next (the left and right hand side of Eq.(62) are denoted, rat(ω) and t(ω), respectively). Then R, L and α are given by:
Figure imgf000033_0001
(63) and the integral is minimum at the physical values of R, L and α (the integral is taken over a frequency interval such that the proximal and distal power spectra are, say, at least 20 times larger than the power spectrum of the noise). For clinically relevant stenoses, exceeding 70%, (percent stenosis is defined as 1 -A/As where A is the "healthy artery cross section area" and As is stenosis area) the reflection coefficient may be considered as a real number independent of frequency [Stergiopulos et all 996).
The main clinical application of the method is in detecting downstream stenosis which would otherwise be hidden from the other modalities. For example, in certain individuals, the internal carotid is situated behind the jaw and thus opaque to B-mode ultrasound. One may thus envision a screening process by which the common carotid is scanned using two probes as described which measure the parameter L (distance of the stenosis from the proximal probe) thereby detecting both the presence and the location of the stenosis in the internal carotid.
Detecting and localizing a stenosis by tracking the motion of the anterior wall of the artery:
The wall of an artery closest to the skin is called the anterior wall, while the side farthest from the skin is the posterior wall. It has been observed that the anterior wall of a carotid undergoes a greater displacement than the posterior wall during a cardiac cycle (Reneman, Hoeks and Westerhof 1996). The same phenomenon might be observed in other peripheral arteries as well. Let ant(t,x) and pos(t,x) be the radii of the anterior and posterior walls at time t at position x along the artery, measured from the centerline of the artery (the exact position of the centerline being arbitrary). Then the corresponding diameter, D(t,x) is given by D(t,x)= ant(t,x)+pos(t,x). Upon arrival of a small pulse, the anterior and posterior undergo a small additional displacement Δant(t,x) and Δpos(t,x) which, in a linear approximation (in view of the smallness of the pressure pulse amplitude), are proportional to the pressure pulse ΔP (t,x). That is Δant(t,x) = aΔP (t,x) and Δpos(t,x) = bΔP (t,x) with a and b proportionality factors.
Assume one measures the anterior wall movement alone (similar considerations hold for the posterior wall, mutatis mutandis). The PWV can be measured by measuring the time between arrival of the peaks of Δant(t,xj) and Δant(t,x2) measured at times ti and t2 , respectively. The PWV, c, is then given by:
C p - t The method is demonstrated, below, using the MMS. Moreover, one can use Eqs.(55-61) with the substitution
— Δ ant ( t , x ) → P ( t, x ) a
The results do not depend on the value of a, only on the fourier transform of Δant(t,0) and Δant(t,Z) which are measured at "0" and "Z".
In Vitro Tests and Results:
In vitro experiments were performed in order to verify this method. The in vitro test apparatus described in Fig. 4 was used to perform the experiments. The pulse generator (exciter) used in the experiments is described in Fig. 3.
Reference is now made to Figs.4, 5and 6 4 illustrating an in-vitro experimental apparatus constructed and operative for determining flow characteristics in simulated non lesioned and lesioned blood vessels,.
Reference is now made to Fig. 4. The fluidics system 51 of Fig. 4 is a recirculating system for providing pulsatile flow. The system 51 includes a pulsatile pump 42 model 1421 A pulsatile blood pump, commercially available from Harvard Apparatus, Inc., Ma, U.S.A., however other suitable pulsatile pumps can be used. The pump 42 allows control over rate, stroke volume and systole/diastole ratio. The pump 42 re-circulates glycerin solution from a reservoir 15 to a reservoir 14.
The system 51 further includes a flexible tube 43 immersed in a water bath 44, to compensate for gravitational effects. The flexible tube 43 is made from Latex and has a length of 120 cm. The flexible tube 43 simulates an artery. The flexible tube 43 is connected to the pulsatile pump 42 and to other system components by Teflon tubes. All the tubes in system 51 have 4 mm internal diameter. A bypass tube 45 allows flow control in the system and simulates flow partition between blood vessels. A Windkessel compliance chamber 46 is located proximal to the flexible tube 43 to control the pressure signal characteristics. A Windkessel compliance chamber 47 and a flow control valve 48 are located distal to flexible tube 43 to simulate the impedance of the vascular bed. The system also includes a flowmeter 1 1 connected distal to the flexible tube 43 and a flowmeter 12 connected to the bypass tube 45. The flown meters 11 and 12 are suitably connected to A/D converter (not shown). The flow meters 1 1 and 12 are model 111 turbine flow meters, commercially available from McMillan Company, TX, U.S.A.. In certain cases, an ultrasonic flow meter model T206, commercially available from Transonic Systems Inc., NY, U.S.A is used. An exciter (5) is connected to the flexible tube (43) through a catheter (6) enable introducing pressure pulses inside the tube.
Reference is now made to Fig. 5, which is a schematic cross sectional view illustrating a part of the fluidics system 51 in detail. An artificial stenosis made of a tube section 55, inserted within the flexible tube 43 is described. The tube section 55 is made from a piece of Teflon tubing. The internal diameter of the artificial stenosis 55 may be varied by using artificial stenosis sections fabricated separately and having various internal diameter.
Reference is now made to Fig. 6. The system 41 includes the system 51. The system 41 also includes a signal conditioner 23 model TCB-500 control unit commercially available from Millar Instruments. Data acquisition was performed using a PC - Pentium 586 (20 with an E series Instruments multifunction I/O board model PC-MIO-16E-4, commercially available from National Inc., TX, U.S.A. The I/O board was controlled by a Labview graphical programming software, commercially available from National Instruments Inc., TX, U.S.A. 10 sec interval of pressure and flow data were sampled at 5000Hz, displayed during the experiments on the monitor and stored on hard disk. Analysis was performed offline using Matlab version 5 software, commercially available from The Math Works, Inc., MA, U.S.A.
Reference is now made to Figs. 7 and 8 illustrating the magnetic motion sensor (MMS) device attached to the in vitro test system 51. The device is used for measuring wall displacement of the tube simulating a blood vessel.
The sensor array measures small changes in diameter along a latex tube while the tube inner diameter is under water pressure variation caused by a pump simulating a human heart. Tests show that the sensors are able to sense movements as small as a few microns in real time and that these movements correspond well to pressure measurements obtained simultaneously using a Radi pressure sensor inside the tubing. In order to minimize the effects of the sensor array on the latex tube Hall Effect sensors were arranged to measure movements of small magnets cemented to the surface of the latex tubing.
A total of six Hall Effect sensors are spaced at 2 CM intervals along the latex tubing and several MM above the tubing. Small rare earth magnets are placed above and below the sensors with there like magnetic poles facing each other. This arrangement creates a magnetic field that is almost linear near the center point between the magnets. The top magnet is fixed relative to the Hall effect sensor, while the lower magnet is free to move with the changing diameter of the tubing. The opposite side of the tubing diameter is fixed to 2 MM diameter posts opposite each sensing position. Each Hall Effect sensor generates an output voltage proportional to the change in magnetic field strength that is in turn proportional to the change in tubing diameter. The sensor voltage is amplified by a low noise instrumentation amplifier followed by a differential output line driver which is drives a set of cables to the nearby data acquisition system.
Experiment for Flow Determination:
The experiment was performed in order to verify the method described herein above for determination of PWV, Volume Flow Rate, axial and radial velocity and other relevant fluid dynamical parameters.
Test Setup:
The experiment was performed using the in vitro test apparatus illustrated in Figs. 4,5,6 using a flexible tube under the action of an external pulsating pump simulating heart beat. The test configuration is illustrated in Fig. 9.
The pump is a pulsating Harvard™ pump producing pressure pulses simulating heartbeats. The flexible tube is made of latex simulates blood vessel wall characteristics of 70 years old man. The latex tube is filled by fluid consists of a 60 % water and 40 % glycerine mixture with a density of 1103 Kg/m and a measured viscosity close to the one measured in blood.
The data was acquired at a sampling rate equal to 5000 Hz and digitized using an A/D board. The data acquisition was monitored with a LABVIEW™ program and then processed through a Matlab™ program (FID), (the sampling rate is much higher than needed for computations)
The MMS system output is voltage signal that follows the tube diameter changes caused by pressure variation in the vessel produced by the pump. The voltage signal is translated into pressure units by means of sensor calibration. For the puφose of calibration we use a single pressure sensor Millar™ in a static configuration. The sensor characteristic obtained was practically linear. Distensibility of the latex tube:
Reference is now made to Fig 10 illustrating a test carried out In order to obtain the Pressure -Area relationship. A pressure sensor 21 (Millar) is positioned in the experimental setup without pump. The pressure sensor is calibrated to zero pressure at atmospheric pressure. Both ends of the tube are closed whereas at one end a syringe is attached to the tube. The length of the tube is 1.31 m and the diameter of the tube filled with fluid at atmospheric pressure is 3.6 mm. The volume of the tube, Vo, (neglecting the Y-connectors) is 13.34 ml. The Syringe capacity is 2.4 ml. Small quantities of fluids are injected into the tube and the pressure read by the Millar sensor is plotted as a function of the logarithm of the volume in the tube, V0 + ΔV. If the latex tube exhibits constant distensibility the following holds
P = Pϋ + pc 2 log -2—
* o which is linear with slope equal to pc Reference is now made to Fig. 11 illustrating this test results. The plot is indeed linear. Where the plot is linear as should. From the slope the value of c = 14.12 was deduced. Since the latex tube was stretched, the length of the tube was practically constant. Therefore the increase in volume, ΔV = LxΔA where ΔA is the increase in cross-sectional area and L the length of the tube. Therefore the latter relation between pressure and volume can be replaced by the pressure-Area (or pressure-diameter) relation (upon simplifying by L the right hand side of the equation):
Figure imgf000038_0001
Pressure- Voltage Characteristics : In addition to pressure and injected volume, MMS output voltage is recorded simultaneously. A plot of pressure as measured by the Millar versus MMS voltage is presented in Fig 12 In the physiological range, it appears that the Pressure-Voltage relation is linear. On the other hand the Pressure-Area is logarithmic and so is the Area-Voltage relation. However, expanding the logarithm in a Taylor series, the relations are practically linear, the higher order terms being negligible. Thus, voltage yields area and pressure. It was found that accuracy is increased upon calibrating the apparatus by means of the volume flow rate, as follows. Through the latex tube, steady flow at a precise value of volume flow rate is applied. The experiment is repeated for several distinct values Q, with ΔP, the corresponding pressure drop is given by
Poiseuille'law
π D Assuming a linear relation between pressure and voltage:
Figure imgf000039_0001
1 7 1 7
The following system is solved for K , K , ΔPo = Po - Po by a least-square method
Figure imgf000039_0002
The value of Po' is the pressure at zero flow.
Pressure Wave Velocity:
Since the pressure-voltage relation is linear, the PWV can be computed directly from the
MMS Voltage as a function of time. Several methods may be used. Basically the method computes the shift in time between arrivals of the pulses at the magnetic sensors. Due to imperfections in the systems such as tube instabilities, pump variations and other factors, there is a spread in the PWV values. A train of 44 pulses was selected and outliers eliminated (less than 8 m s and more than 20 m/s).
The computed PWV is c= 13.79 ±1.65 m/s .
The pulses measured by the MMS are illustrated in Fig. 13 WO 00/55579 PCTtlLOO/00172
Flow Computation: the results of two measurements are presented. The measured mean volume flow rates using a graduated cylinder wasl lO ml/min and 204 ml/min. In addition a Flow-meter, Mac-Millan model FM1 1 1 was inserted distally for validation. The Flow-meter consists in a turbine, through which the liquid flows. Due to inertia of the turbine, the full amplitude of the flow is effectively truncated. Numerical computations using Model 1 and model 2 were applied to the two configurations.
Results using Model 2 The computed volume flow rate using model 2, for the two cases, is plotted in Fig 14. For comparison, the output of the Flow-Meter (FM) appears on the same plot. The volume flow rate as measured by the flow-Meter has a smaller amplitude due probably to inertia. Plots of the Wall Shear Stress as function of time for volume flow rate 120 ml/min (top) and 200 ml/sec(below).are illustrated in Fig. 15for the two experiments.
Reference is now made to Fig. 16 illustrating a plot of the axial velocity profile for a single period with volume flow rate 120 ml/min. It is convenient to measure time by an angular variable, a whole period being 360 degrees. Velocity profiles as function of time for volume flow rate 120 ml/min
The maximum (or peak) velocity is seen to be situated along the centerline of the tube. In addition to the flow-Meter peak Doppler velocity was measured using a 0.0014 inch Doppler guide wire (Flowire™, Cardiometrics, Inc., Mountain View CA). A proprietary real-time fast Fourier analyzer (Flowmap™ Cardiometrics, Inc.) with automated tracking of the maximal velocity of the Doppler spectrum was employed to measure peak Doppler velocity. In an angle of view oriented downstream and covering the whole tube, the Doppler shift reflected by red cells is recorded (we use corn-flour starch, instead). Reference is now made to Fig. 17 illustrating a plot of the calculated centerline axial velocity using Model 1 (continuous curve) and the peak velocity as measured by the Flow ire. The volume flow rate is 120 ml/min. Results using Model 1 :
The computed volume flow rate using model 1 is plotted in Fig. 18 together with the output of the Flow-Meter. The parameters chosen were: β =1, Cu =1, Cv =1. The results are quite insensitive to small changes in these parameters. Model 1 is more limited than Model 2, since its only output is volume flow rate. In the present situation were the tube is circular and there is no swirl, it is not advantageous to use Model 1.
Comparing Model 1 and Model 2: Reference is now made to Fig. 19 The volume flow rates given by Model 1 and Model 2 are compared and are almost identical.
Experiment for detecting and localizing stenosis:
In order to verify the method for stenosis detection an localization, in vitro experiments were performed using the in vitro test apparatus illustrated in Figs 4.5 and 6. Tube diameter was measured at two points using the MMS device illustrated in Figs. 7 and 8. The MMS, due to lack of stability was found unsuitable for detecting stenosis using physiological pressure signal generated by a pump simulating physiological pressure signal caused by heart beats. Instead, an excited short duration pressure pulse generated by the exciter illustrated in Fig. 3 was used. The test set up is illustrated in Fig. 20
Reference is now made to Fig. 21 which is a plot of the proximal and distal signal measured by the MMS. In this experiment the stenosis has a diameter of 1 mm and a length of 1 cm and is located at a distance of 16 cm from the proximal magnet.
Reference is now made to Fig 22 which is a zoom about the peaks of the pulses illustrated in Fig. 21. "A" and "B are the pulses measured by proximal and distal magnet, respectively. The time between peaks "A" and "B" is 7.4 msec. Since the distance between magnet is exactly 10.4 cm, it follows that the PWV, c, is equal to c=10.4cm/7.4msec = 14.0541 m/sec. Experiment Results:
Experiments were performed on blunt stenoses with inner diameter (d) of 1mm and 1,5 mm for distances (L) of 13, 16,20 and 25 cm from the proximal magnet (3, 6, 10, 15 cm from the distal magnet). The results are summarized in the table 1 (α is the attenuation coefficient).
Table 1 : 1 mm diameter Stenosis
Figure imgf000042_0001
Table 2: 1.5 mm diameter Stenosis
Figure imgf000042_0002
The presence of stenosis is always detected and its distance well estimated. The test data, (Teflon tube diameter) was measured using the MMS which used as a demonstration device. By using Medical Ultrasound systems or other well-developed systems the result will be more accurate.
References
G.A. Johnson, H.S Borovetz and J.L. Anderson "A Model of Pulsatile Flow in a
Uniform Deformable Vessel", J. Biomechanics 1992, 25, 91-100.
Tadeusz Powalowski, Zbigniew Trawinski "Noninvasive Evaluation of the elasticity of common Carotid artery Wall" Archives of Acoustics (1994), 19, 451-465.
Fung Y.C. Biomechanics: Mechanical Properties of Living tissues ", Springer-Verlag, New York, 1981.
R.S. Reneman, A. P.G. Hoeks and N. Westerhof "Non-invasive Assesment of Artery wall properties in humans - methods and inteφretation" Journal of Vascular Investigation (1996) 2:2: 53-64.
Arnold P.G. Hoeks and Robert Reneman "Biophysical Principles of Vascular diagnosis" J. Clin. Ultrasound (1995) 23:71-79.
Streeter, V.L, W.F. Keitzer and D.F. Bohr "Pulsatile pressure and flow through distensible vessels" (1963) Cir,c. Res. 13: 3-20.
Langewouters G.J., Wesseling K.H., goedhard K.H. "The static elastic properties of 45 human thoracic and 20 abdominal aortas in vitro and the parameters of a new model" J. Biomechanics 1984, 17, 425-435.
Stergiopulos N., Young D. F. and Rogge T.R.., "Computer simulations of arterial flow with applications to arterial and aortic stenoses" J. Biomechanics 1992, 25, 1477-1488.
Nichols W.W. and O'Rourke M. F., (1998) "McDonald's Blood flow in arteries: Theoretical, experimental and clinical Principles", fourth Edition

Claims

WHA T IS CLAIMED IS:
1. An apparatus for determining volume flow, blood velocity profile, artery wall properties of a tubular conduit system and stenosis identification and localization, said apparatus comprising: a means for generating an artificial pressure signal or an artificial pressure wave velocity; a means for measuring artery diameter or displacement resulting from said artificial pressure signal or an artificial pressure wave velocity; a processor unit operatively connected to said measuring means; a program for controlling the processor unit, wherein said processor unit is operative with said program to receive said signal which is represented of the measure of said artery diameter or displacement resulting from said artificial pressure signal or an artificial pressure wave velocity and determine volume flow, blood velocity profile, artery wall properties and stenosis identification and localization.
2. The apparatus according to claim 1, wherein said processor unit is operative to select a method from a plurality of methods to generate artificial pressure signal or an artificial pressure wave velocity.
3. The apparatus according to claim 1, wherein said tubular conduit system is a blood vessel system and said processor unit is operative to detect changes in arterial characteristics.
4. The apparatus according to claim 3 wherein said processor unit is operative to determine volume flow.
5. The apparatus according to claim 3 wherein said processor unit is operative to detect stenosis.
6. The apparatus according to claim 3 wherein said processor unit is operative to determine blood velocity profile.
7. The apparatus according to claim 1, wherein the measuring means is by ultrasound or magnetic motion sensor.
8. The apparatus according to claim 1, wherein the measuring means is by ultrasound.
9. The apparatus according to claim 1 , wherein the measuring means is by magnetic motion sensor.
10. The apparatus according to claim 1, wherein the means for generating a pressure signal is in by a non-invasive means.
1 1. The apparatus according to claim 1 , wherein the means for generating a pressure signal is by an exciter.
12. The apparatus according to claim 1, wherein the non-invasive means for generating a comprises a mechanical and/or electrical means.
13. The apparatus according to claim 1, wherein the mechanical non-invasive means for generating a comprises applying pressure to the carotid.
14. The apparatus according to claim 3 wherein said signal is a plurality of discrete signals said processor unit is operative to sample said discrete signals and receive pressure wave velocity data.
15. The apparatus according to claim 14 wherein said processor unit is operative to perform a single pressure function using said discrete signals and said pressure wave velocity data.
16. The apparatus of claim 3 wherein said measuring means measures the artery diameter or displacement at two or more points of the tubular conduit.
17. A method for determining volume flow, blood velocity profile, and/or artery wall properties of a tubular conduit system and stenosis identification and localization, comprising: generating an artificial pressure signal or an artificial pressure wave velocity; and measuring artery diameter or displacement resulting from said artificial pressure signal or an artificial pressure wave velocity; thereby determining volume flow, blood velocity profile, artery wall properties of a tubular conduit system and stenosis identification and localization.
18. The method of claim 17, wherein said method comprises a plurality of methods to generate artificial pressure signal or an artificial pressure wave velocity.
19. The method of claim 17, wherein said tubular conduit system is a blood vessel system and said processor unit is operative to detect changes in arterial characteristics.
20. The method of claim 17, wherein measuring is by means of ultrasound or magnetic motion sensor.
21. The method of claim 17, wherein the measuring means is by ultrasound.
22. The method of claim 17, wherein the measuring means is by magnetic motion sensor.
23. The method of claim 17, wherein the means for generating a pressure signal is in by a non-invasive means.
24. The method of claim 17, wherein the means for generating a pressure signal is by an exciter.
25. The method of claim 17, wherein the non-invasive means for generating a comprises a mechanical and/or electrical means.
26. The method of claim 17, wherein the mechanical non-invasive means for generating a comprises applying pressure to the carotid.
27. The method of claim 17, wherein said signal is a plurality of discrete signals said processor unit is operative to sample said discrete signals and receive pressure wave velocity data.
28. The method of claim 17, wherein said processor unit is operative to perform a single pressure function using said discrete signals and said pressure wave velocity data.
29. The method of claim 17, wherein said measuring means measures the artery diameter or displacement at two points of the tubular conduit.
30. A system determining volume flow, blood velocity profile, artery wall properties of a tubular conduit system and stenosis identification and localization, said system comprising: a means for generating an artificial pressure signal or an artificial pressure wave velocity; a means for measuring artery diameter or displacement resulting from said artificial pressure signal or an artificial pressure wave velocity; a processor unit operatively connected to said measuring means; a program for controlling the processor unit, wherein said processor unit is operative with said program to receive said signal which is represented of the measure of said artery diameter or displacement resulting from said artificial pressure signal or an artificial pressure wave velocity and determine volume flow, blood velocity profile, artery wall properties and stenosis identification and localization.
31. The system according to claim 30, wherein said processor unit is operative to select a method from a plurality of methods to generate artificial pressure signal or an artificial pressure wave velocity.
32. The system according to claim 30, wherein said tubular conduit system is a blood vessel system and said processor unit is operative to detect changes in arterial characteristics.
33. The system according to claim 30, wherein said processor unit is operative to determine volume flow.
34. The system according to claim 30, wherein said processor unit is operative to detect stenosis.
35. The system according to claim 30, wherein said processor unit is operative to determine blood velocity profile.
36. The system according to claim 30, wherein the measuring means is by ultrasound or magnetic motion sensor.
37. The system according to claim 30, wherein the measuring means is by ultrasound.
38. The system according to claim 30, wherein the measuring means is by magnetic motion sensor.
39. The system according to claim 30, wherein the means for generating a pressure signal is in by a non-invasive means.
40. The system according to claim 30, wherein the means for generating a pressure signal is by an exciter.
41. The system according to claim 30, wherein the non-invasive means for generating a comprises a mechanical and/or electrical means.
42. The system according to claim 30, wherein the mechanical non-invasive means for generating a comprises applying pressure to the carotid.
43. The system according to claim 30, wherein said signal is a plurality of discrete signals said processor unit is operative to sample said discrete signals and receive pressure wave velocity data.
44. The system according to claim 43 wherein said processor unit is operative to perform a single pressure function using said discrete signals and said pressure wave velocity data.
45. The system of claim 30, wherein said measuring means measures the artery diameter or displacement at two points of the tubular conduit.
PCT/IL2000/000172 1999-03-16 2000-03-16 A system and method for detection and characterization of stenosis, blood vessels flow and vessel walls properties using vessel geometrical measurements WO2000055579A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2000233210A AU2000233210A1 (en) 1999-03-16 2000-03-16 A system and method for detection and characterization of stenosis, blood vessels flow and vessel walls properties using vessel geometrical measurements

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12456799P 1999-03-16 1999-03-16
US60/124,567 1999-03-16

Publications (2)

Publication Number Publication Date
WO2000055579A2 true WO2000055579A2 (en) 2000-09-21
WO2000055579A3 WO2000055579A3 (en) 2001-01-11

Family

ID=22415619

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2000/000172 WO2000055579A2 (en) 1999-03-16 2000-03-16 A system and method for detection and characterization of stenosis, blood vessels flow and vessel walls properties using vessel geometrical measurements

Country Status (2)

Country Link
AU (1) AU2000233210A1 (en)
WO (1) WO2000055579A2 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1317902A1 (en) * 2001-12-10 2003-06-11 Kabushiki Gaisha K-and-S Biological data observation apparatus
WO2017198871A1 (en) 2016-05-20 2017-11-23 Koninklijke Philips N.V. Determining pulse wave velocity using intravascular pressure measurement and external ultrasound imaging, and associated devices, systems, and methods
CN108051141A (en) * 2017-12-29 2018-05-18 四川大学华西医院 A kind of imitative body of adjustable-pressure ultrasound
CN110198657A (en) * 2016-12-01 2019-09-03 爱德华兹生命科学公司 Aortostenosis classification
US10736593B2 (en) 2012-09-25 2020-08-11 Canon Medical Systems Corporation X-ray diagnostic apparatus and medical image processing apparatus
US10806352B2 (en) 2016-11-29 2020-10-20 Foundry Innovation & Research 1, Ltd. Wireless vascular monitoring implants
US10806428B2 (en) 2015-02-12 2020-10-20 Foundry Innovation & Research 1, Ltd. Implantable devices and related methods for heart failure monitoring
US11039813B2 (en) 2015-08-03 2021-06-22 Foundry Innovation & Research 1, Ltd. Devices and methods for measurement of Vena Cava dimensions, pressure and oxygen saturation
US11206992B2 (en) 2016-08-11 2021-12-28 Foundry Innovation & Research 1, Ltd. Wireless resonant circuit and variable inductance vascular monitoring implants and anchoring structures therefore
US11564596B2 (en) 2016-08-11 2023-01-31 Foundry Innovation & Research 1, Ltd. Systems and methods for patient fluid management
US11701018B2 (en) 2016-08-11 2023-07-18 Foundry Innovation & Research 1, Ltd. Wireless resonant circuit and variable inductance vascular monitoring implants and anchoring structures therefore
US11779238B2 (en) 2017-05-31 2023-10-10 Foundry Innovation & Research 1, Ltd. Implantable sensors for vascular monitoring
USD1018557S1 (en) 2019-05-17 2024-03-19 Opsens, Inc. Display screen or portion thereof with graphical user interface
US11944495B2 (en) 2017-05-31 2024-04-02 Foundry Innovation & Research 1, Ltd. Implantable ultrasonic vascular sensor

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4586514A (en) * 1983-08-10 1986-05-06 Biotronics Instruments Phonoangiographic spectral analysing apparatus
US5241963A (en) * 1991-06-12 1993-09-07 Florida Atlantic University Research Corp. Method for detecting the onset and relative degree of atherosclerosis in humans
US5409010A (en) * 1992-05-19 1995-04-25 Board Of Regents Of The University Of Washington Vector doppler medical devices for blood velocity studies
US5429136A (en) * 1993-04-21 1995-07-04 Devices For Vascular Intervention, Inc. Imaging atherectomy apparatus
US5715826A (en) * 1993-09-14 1998-02-10 British Technology Group Limited Method and device for assessing the state of blood vessels

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4586514A (en) * 1983-08-10 1986-05-06 Biotronics Instruments Phonoangiographic spectral analysing apparatus
US5241963A (en) * 1991-06-12 1993-09-07 Florida Atlantic University Research Corp. Method for detecting the onset and relative degree of atherosclerosis in humans
US5297556A (en) * 1991-06-12 1994-03-29 Florida Atlantic University Research Corp. Method of detecting atherosclerosis while excluding motion artifacts
US5409010A (en) * 1992-05-19 1995-04-25 Board Of Regents Of The University Of Washington Vector doppler medical devices for blood velocity studies
US5429136A (en) * 1993-04-21 1995-07-04 Devices For Vascular Intervention, Inc. Imaging atherectomy apparatus
US5715826A (en) * 1993-09-14 1998-02-10 British Technology Group Limited Method and device for assessing the state of blood vessels

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6953435B2 (en) 2001-12-10 2005-10-11 Kabushiki Gaisha K -And- S Biological data observation apparatus
EP1317902A1 (en) * 2001-12-10 2003-06-11 Kabushiki Gaisha K-and-S Biological data observation apparatus
US10736593B2 (en) 2012-09-25 2020-08-11 Canon Medical Systems Corporation X-ray diagnostic apparatus and medical image processing apparatus
US10905393B2 (en) 2015-02-12 2021-02-02 Foundry Innovation & Research 1, Ltd. Implantable devices and related methods for heart failure monitoring
US10806428B2 (en) 2015-02-12 2020-10-20 Foundry Innovation & Research 1, Ltd. Implantable devices and related methods for heart failure monitoring
US11039813B2 (en) 2015-08-03 2021-06-22 Foundry Innovation & Research 1, Ltd. Devices and methods for measurement of Vena Cava dimensions, pressure and oxygen saturation
CN109152541A (en) * 2016-05-20 2019-01-04 皇家飞利浦有限公司 Pulse wave velocity and associated equipment, system and method are determined using the measurement of arteries and veins overpressure and external ultrasound imaging
WO2017198871A1 (en) 2016-05-20 2017-11-23 Koninklijke Philips N.V. Determining pulse wave velocity using intravascular pressure measurement and external ultrasound imaging, and associated devices, systems, and methods
JP2019518518A (en) * 2016-05-20 2019-07-04 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. Associated devices, systems, and methods for determining pulse wave velocity using intravascular pressure measurement and external ultrasound imaging
US11701018B2 (en) 2016-08-11 2023-07-18 Foundry Innovation & Research 1, Ltd. Wireless resonant circuit and variable inductance vascular monitoring implants and anchoring structures therefore
US11206992B2 (en) 2016-08-11 2021-12-28 Foundry Innovation & Research 1, Ltd. Wireless resonant circuit and variable inductance vascular monitoring implants and anchoring structures therefore
US11564596B2 (en) 2016-08-11 2023-01-31 Foundry Innovation & Research 1, Ltd. Systems and methods for patient fluid management
US10806352B2 (en) 2016-11-29 2020-10-20 Foundry Innovation & Research 1, Ltd. Wireless vascular monitoring implants
EP3547904A4 (en) * 2016-12-01 2019-11-20 Edwards Lifesciences Corporation Aortic stenosis classification
CN110198657A (en) * 2016-12-01 2019-09-03 爱德华兹生命科学公司 Aortostenosis classification
US11779238B2 (en) 2017-05-31 2023-10-10 Foundry Innovation & Research 1, Ltd. Implantable sensors for vascular monitoring
US11944495B2 (en) 2017-05-31 2024-04-02 Foundry Innovation & Research 1, Ltd. Implantable ultrasonic vascular sensor
CN108051141A (en) * 2017-12-29 2018-05-18 四川大学华西医院 A kind of imitative body of adjustable-pressure ultrasound
USD1018557S1 (en) 2019-05-17 2024-03-19 Opsens, Inc. Display screen or portion thereof with graphical user interface

Also Published As

Publication number Publication date
AU2000233210A1 (en) 2000-10-04
WO2000055579A3 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
US6354999B1 (en) System and method for detecting, localizing, and characterizing occlusions and aneurysms in a vessel
US6193669B1 (en) System and method for detecting, localizing, and characterizing occlusions, stent positioning, dissections and aneurysms in a vessel
US6471656B1 (en) Method and system for pressure based measurements of CFR and additional clinical hemodynamic parameters
WO1999034724A2 (en) Characterizing blood vessel using multi-point pressure measurements
EP1251769A1 (en) A method and system for pressure based measurements of cfr and additional clinical hemodynamic parameters
WO2001013779A2 (en) A method and system for stenosis identification, localization and characterization using pressure measurements
CN101516270B (en) Ultrasonographic device
WO2000055579A2 (en) A system and method for detection and characterization of stenosis, blood vessels flow and vessel walls properties using vessel geometrical measurements
JPWO2006043528A1 (en) Ultrasonic diagnostic apparatus and control method of ultrasonic diagnostic apparatus
WO2001021057A2 (en) A method and system for determination of ffr based on flow rate measurements
JPH11513276A (en) Detection of vascular stenosis in chronic hemodialysis patients
Olesen et al. Noninvasive estimation of pressure changes using 2-D vector velocity ultrasound: an experimental study with in vivo examples
US20040088123A1 (en) Method for real-time monitoring of cardiac output and blood flow in arteries and apparatus for implementing the same
EP1079727A1 (en) Apparatus and method for identification and characterization of lesions and therapeutic success by flow disturbances analysis
EP3831307A1 (en) An apparatus for determining a physiological parameter relating to a vessel
Urchuk et al. 1995 SMR young investigators' award finalist: MR measurement of time‐dependent blood pressure variations
Hartley Review of intracoronary Doppler catheters
JP2008161546A (en) Ultrasonic diagnostic apparatus
JP5014132B2 (en) Ultrasonic diagnostic equipment
EP3922173A1 (en) Systems and methods for obtaining a pulse wave velocity measurement
Beard et al. A Doppler flowmeter for use in theatre
CN109350124A (en) The continuous pressure measuring system of minimally-invasive blood vessel based on ultrasonic transducer
Hutchison et al. Stability of flow patterns in the in vivo post-stenotic velocity field
Kraft et al. In VitroValidation of Rapid MR Measurement of Wave Velocity
Seo Continuous and non-invasive blood pressure monitoring using ultrasonic methods

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WPC Withdrawal of priority claims after completion of the technical preparations for international publication
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP